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Abstract  
 
This dissertation concentrates on two emerging trends influenced by national policies that 
pose potential public health and occupational risks for those involved in animal food production. 
These trends include the increased use of antimicrobials and its impact on antimicrobial 
resistance (AMR) and agricultural policies to increase animal production and the re-emergence of 
a zoonotic disease, brucellosis. Overall the goal of this dissertation is to characterize and better 
understand the interaction between agricultural policy, animal husbandry practices, occupational 
risks and public health. Studies in this dissertation provide information on the re-emergence of a 
zoonotic disease and current and proposed policy frameworks to manage and protect public 
health from AMR. Diseases that are transmissible either directly or indirectly between animals 
and humans, such as AMR and brucellosis, pose significant threats to global animal and human 
health. As countries continue to adapt policy to increase food production, the spread and growth 
of disease needs to be considered. Findings from this research can be used to inform further 
studies on the impact of agriculture policies and infectious diseases in low resource settings, 
strengthen future policy, inform future training and education initiatives and provide greater 
awareness and understanding of factors influencing emergence and re-emergence of infectious 
diseases. 
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Intensifying animal production and public health   
Policy influences occupational health risks for those involved in animal food production. 
The nature of these risks is changing as practices in animal food production shift and expand 
globally (Tomley & Shirley, 2009; Thornton, 2010; Otte et al., 2007; Richter et al., 2015). Risk is 
particularly high among those involved in agriculture in low- and middle-income countries where 
there are close human-livestock interactions and regulation and enforcements are often limited 
(FAO, 2017; Weiss et al., 2004; Graham et al., 2008). Responses to occupational health risks 
among agricultural workers differ fundamentally across countries. For many countries, 
governments create agricultural policies to address various objectives including poverty 
reduction, agricultural development and addressing food security issues (Brooks, 2010; Delgado 
et al., 1999). Often these policies have unintentional consequences on human and animal health 
(Morse, 2001; Fresco, 2009; Jones et al., 2008; Perry et al., 2008). This research focuses on 
understanding the consequences of the expansion and intensification of food animal production 
and on the role of policy in how countries are responding and adapting to these changes.  
AMR poses a significant threat to human and animal health (World Bank, 2016; FAO, 
2016). Often, changing animal production systems modify and increase transmission of zoonotic 
disease infections in animals and humans (Richter et al., 2015). Drivers of changes in agricultural 
systems include new or adapted regulations and policies on agricultural and veterinary practices 
(Brooks, 2010; Weiss et al., 2004; Richter et al., 2015). National policies or a lack of policies, can 
exacerbate infectious disease emergence and re-emergence events (Perry et al., 2008; Otte et al., 
2007). One region that is experiencing significant changes in its animal production systems is 
Southeast Asia. This region is experiencing rapid economic growth and dramatic increases in 
animal production and consumption (Devanandra et al., 2013). Population growth, urbanization 
and income growth are the key drivers of the increasing demand for livestock products and these 
three influencing factors are projected to increase for the next three decades (Thornton, 2010).  
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Governments in many countries in Southeast Asia set targets for livestock production and 
establish agricultural policies to reach these targets. For instance, in Lao PDR (Laos), the 
government is working to increase livestock production to reduce poverty and increase meat 
consumption from 22 to 50 kg per person in rural areas and 33 to 70 kg per person in urban areas 
(Theungphachan, 2008). Laos has promoted livestock production through national policies such 
as the Livestock Development Plan enacted through the Ministry of Agriculture and Forestry 
(Millar & Photakoun, 2008). Under this plan, livestock production is supported through national 
vaccination programs, animal disease response and prevention activities and training in livestock 
management for small-scale farmers.  
Policies to promote livestock production are often effective at increasing animal 
production, however, changes in agricultural policies and animal production systems can have 
considerable positive and negative impacts on social equity, public health, natural resources and 
the economic growth of countries (Otte et al., 2007; Keesing et al., 2010; Perry et al., 2008; Jones 
et al., 2008). An important unintended consequence of the intensification of animal production 
includes increasing infectious disease and emergence events such as antimicrobial resistance 
(AMR) (Greger et al., 2007; Keesing et al., 2010).  
Brucellosis  
One example of agricultural policies and changes in agricultural production influencing the 
re-emergence of an infectious disease is brucellosis in Thailand. Brucellosis poses a significant 
public health problem in many regions of the world, particularly in low-income countries. The 
disease is commonly misdiagnosed as other febrile illnesses such as malaria, dengue or typhoid 
fever (Dean et al., 2012; Bamaiyi et al., 2014). Brucellosis also known as undulant fever, Malta 
fever, Crimean fever, and Mediterranean fever, is a zoonotic disease caused by bacteria of the 
genus Brucella (Seleem et al. 2010). There are several known species of the Brucella organism 
and some of these are pathogenic to humans (Seleem et al. 2010; Godfroid et al., 2011). The most 
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virulent to humans and widely distributed species of Brucella is Brucella melitensis (B. 
melitensis) whose primary animal hosts are sheep and goats (Godfroid et al., 2011). Although B. 
melitensis is the most virulent among the Brucella species, any species of Brucella can potentially 
cause severe complications in humans (Seleem et al. 2010).   
B. melitensis in humans can present mild to severe symptoms depending on the course and 
timeliness of treatment (Srinoy et al., 1999). The Brucella organism evades the immune system 
through intracellular localization, causing chronic illness and disability if left untreated (Roth et 
al., 2003). B. melitensis can cause fever, sweating, fatigue, weight loss, headache and joint and 
muscle pain (Seleem et al. 2010; Dean et al., 2012). Joint and muscle pain are often considered 
clinical manifestations that distinguish brucellosis from other febrile illnesses (Seleem et al. 
2010). The most common complication among clinically diagnosed brucellosis patients is 
osteoarticular disease (Rotes-Qurol, 1957). The true rate of osteoarticular disease from brucellosis 
is unknown and global estimates range from 10% - 85% among those with a clinical diagnosis 
(Seleem et al. 2010; Rotes-Qurol, 1957). Spondylitis (inflammation of the vertebra) is the most 
prevalent and severe clinical form of osteoarticular disease (Rotes-Qurol, 1957).  
The most severe complication in humans, Brucella endocarditis, occurs in less than 2% of 
cases and is the most common cause of death from the disease (Madkour, 2001; Gunes et al., 
2009). Brucellosis poses a significant risk to pregnant women as it can cause spontaneous 
abortion or intrauterine transmission to the infant (Seleem et al. 2010). Brucellosis typically 
causes reproductive issues in animals including abortion, premature births, decreased fertility and 
retained placenta (Corbel, 2006). Other common symptoms in animals can include decreased 
milk production, lameness, mastitis, arthritis, epididymitis, hygromas and abscesses (Seleem et al. 
2010). Clinical manifestation of brucellosis in animals or humans is not always specific and 
diagnosis supported by laboratory tests is essential to confirm a case (Seleem et al. 2010). 
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Infected animals excrete Brucella in urine, milk, placenta, and the products of miscarriage 
(OIE, 2012). Typical transmission to humans occurs via direct contact with infected animals, 
placentas or aborted fetuses, or consumption of infected animal products, primarily non-
pasteurized milk products or insufficiently cooked or raw meat (Laosiritaworn et al., 2007). 
Butchering can pose a risk for transmission if personal protective equipment is not used when in 
contact with an infected animal’s blood, fluid or tissue (Seleem et al. 2010).  Brucella can survive 
for up to three weeks in frozen meat and up to three months in goat cheese (Molavi et al., 2014). 
Human to human transmission is very rare although it can occur through blood transfusion, tissue 
transplantation, breast-feeding, or sexual contact (Ruben et al., 1991). Infection can also occur 
through skin lesions, conjunctivae or from inhaling contaminated dust or aerosols (Spink, 1956).  
Recommended treatment in uncomplicated acute brucellosis in humans includes combination 
therapy with antibiotics such as tetracycline or doxycycline administered in conjunction with an 
amino-glycoside such as streptomycin or gentamicin (Seleem et al. 2010). In uncomplicated 
cases, antibiotic treatment should last up to six weeks. In complicated cases, antibiotic treatment 
usually lasts twelve weeks to six months and includes at least three drugs (Yousefi-Nooraie et al., 
2012). Treatment in pregnant women is difficult as recommended drugs have adverse effects on 
the fetus (Seleem et al. 2010). There is no known treatment for brucellosis infection in animals 
(Anothaisinthawee et al., 2012). Prevention of brucellosis in animals can occur through 
vaccination and agricultural practices (Anothaisinthawee et al., 2012).  Vaccination has failed to 
control brucellosis in low-income countries due to high expense and limited accessibility (Blasco 
et al., 1997). There is a rising risk of brucellosis infection globally with the increasing rate of 
international travel, migration and commerce (Dean et al., 2012). According to a 2013 study of 
returned travelers to Europe and the U.S. from the Middle East and North Africa, brucellosis was 
the third most common cause of febrile illness (Leder et al., 2013).  
  
6 
There were no reported human cases of brucellosis in Thailand from 1970 until 2003 when 
three cases of Brucella melitensis in small-scale goat farmers were reported (Chiewchanyont et 
al., 2011). Brucellosis is currently considered endemic and human and animal brucellosis is now 
a notifiable disease in Thailand (Chiewchanyont et al., 2011). Literature reports varying levels of 
the disease in humans however, researchers estimate that 80% of all cases are related to exposure 
to goats (Chiewchanyont et al., 2011). A 2012 study in Nakhon Nayok province found that 
45.33% of goat farmers sampled had seropositive antibodies to Brucella melitensis (Ekpanyaskul 
et al., 2012). According to the Thai Bureau of Epidemiology National Surveillance System, the 
current incidence in Thailand is between 5 and 11 reported and confirmed human cases per year 
(Thai Bureau of Epidemiology, 2016). Estimates for other Brucella species specific 
seroprevalence in humans were not identified.  
One potential contributing factor to the re-emergence of brucellosis has been the substantial 
increase in goat farming throughout Thailand (Nakavisut et al., 2014). The number of registered 
goats in Thailand has increased from 177,944 in 2002 to 444,744 in 2007, representing a 2.5-fold 
increase (Nakavisut et al., 2014). Since the early 2000s the Thai government has promoted the 
expansion of small-scale goat farming through agricultural policies that encourage goat rearing 
(Nakavisut et al., 2014). These policies were primarily created to increase Muslim food 
production with goat farming originating in the southern part of Thailand but have since 
expanded throughout the country (Nakavisut et al., 2014). Goats are promoted as a profitable 
livestock to supplement household income for low-income farmers throughout low- and middle-
income countries because of their low maintenance costs and grazing habits (Devendra et al., 
2013; Anothaisinthawee et al., 2012).  
In Thailand, most goat farmers left rice farming to enter into animal husbandry for greater 
economic benefits (Laosiritaworn et al., 2007). The majority of goat farms in Thailand are 
relatively small in scale averaging between 15-20 goats per farm (Anothaisinthawee et al., 2012). 
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Goats in Thailand are primarily used for their meat with consumption of goat milk becoming 
increasingly more popular as well as the use of goat placenta in cosmetic products 
(Anothaisinthawee et al., 2012). 
Despite the re-emergence of brucellosis in humans in Thailand, a limited number of studies 
have been conducted that examine small-scale farmers and their knowledge, attitudes and 
behaviors towards the disease. The majority of research on brucellosis in Thailand has focused on 
seroprevalence in cattle on large-scale dairy farms. This has contributed to a gap in knowledge on 
brucellosis in goat husbandry compared to other species in Thailand (Bordier et al., 2013). There 
is a need for better-designed studies to further the evidence base for more effective prevention 
and control efforts (Plumb et al., 2013).  
Antimicrobial Resistance  
Another emerging global health and occupational threat to animal production workers 
influenced by the intensification of animal production systems is AMR. Antimicrobials refers to a 
broad class of drugs manufactured to kill or halt the growth of microorganisms. AMR occurs 
when microorganisms become resistant to drugs manufactured to kill the organism or halt its 
growth (WHO, 2012). Antimicrobials are becoming increasingly ineffective at killing 
microorganisms due to the spread of AMR (CDC, 2013). This emerging threat poses a risk to 
human and animal health as it can lead to an increase in infectious diseases, difficulty in treating 
common infections, uncertainty in success of surgical procedures and significant economic losses 
(Ventola, 2015).  
All antimicrobial use contributes to the growth and spread of AMR however, an area of 
concern is the misuse and overuse of antimicrobials in livestock production. Antimicrobials are 
used in animal (terrestrial and aquatic) production systems throughout the world. In intensive 
food-animal production settings antibiotics are routinely used for nontherapeutic purposes mainly 
disease prevention and growth promotion (Van Boeckela et al., 2015). Critically important 
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antibiotics for humans, such as colistin, are routinely used in animal production in certain 
countries (Nhung et al., 2016). Antimicrobials are often inexpensive and readily available for use 
in animals (Nhung et al., 2016). In many countries farmers and producers can purchase 
antimicrobial drugs over the counter and are often given limited instructions and information 
about the drug. Additionally, there is limited control and regulation to ensure the quality of the 
drugs (Gelband & Delahoy, 2014).  
Antimicrobial use in agriculture is of concern for human health because it increases the risk 
for AMR and because antimicrobial-resistant microorganisms in livestock spread to humans in 
multiple ways. Resistant bacteria as well as antimicrobial residues from food-animal production 
can be spread widely in the environment with treated animals excreting active, unmetabolized 
antimicrobials. Agriculture workers are particularly vulnerable to AMR as they have a very high 
exposure risk through direct contact with infected animals and through indirect exposure through 
the environment (Marshall et al., 2011).  
Antimicrobial resistance (AMR) poses significant economic threats to animal production 
systems because of potential adverse trade outcomes from contaminated animal product exports 
and negative impacts on animal health. AMR is expected to lead to reductions in global Gross 
Domestic Products, increases in poverty including an increasing inequality between high and low 
income countries and a decline in global livestock production (Ventola, 2015). The World Bank 
estimates that AMR “directly undermines the prospect for attaining the Sustainable Development 
Goal for 2030 to reduce inequality” (World Bank, 2016). It is estimated that by 2050, AMR in 
humans could lead to 10 million deaths per year and cumulative lost outputs worth up to US $100 
trillion across the world (O’Neill, 2016).   
With an international food trade exceeding 200 billion USD annually, agriculturally-linked 
AMR presents a global threat to public health, food safety, and livestock-based livelihoods 
(World Bank, 2016). Occupational threats of AMR can also pose a population-level risk as 
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farmers and their families providing a conduit for further spreading AMR infectious diseases in 
communities and hospitals (Mølbak et al., 1999; Loeffen et al., 2005). Farmers are also vulnerable 
to the economic impacts of AMR due to losses in animal production with increasing ineffective 
antimicrobials for treating different diseases and adverse trade impacts (WHO, 2016).  
AMR is of particular concern in Southeast Asia where a significant proportion of the 
population is dependent upon livestock production (Richter et al., 2015). AMR in animal 
pathogens and the loss of antimicrobials carries significant economic and food security risks for 
this region (Richter et al., 2015). Countries in Southeast Asia are also subject to a growing market 
for counterfeit and sub-quality antimicrobials (WHO, 2010). It is estimated that as high as 60% of 
antimicrobials used in Asia and Africa are substandard (World Bank, 2016). These practices are 
alarming as any use of antimicrobials accelerates the rate of AMR (Centre for Science and the 
Environment, 2017; World Bank, 2016). Effectively addressing AMR presents significant 
challenges due to its complex and multi-sectoral nature. Finding affordable strategies and tools to 
manage AMR in low- and middle-income countries is particularly important because of limited 
resources and evidence based solutions.  
Limited actions have taken place among countries in Southeast Asian to address AMR. Many 
countries in this region have inadequate capacity including weak legal and regulatory frameworks 
and insufficient financial and human resources to effectively address AMR. Countries often have 
minimal regulation, laws or guidelines to promote rationale and responsible antimicrobial use and 
insufficient guidelines and regulations on infection prevention and control at the farm level. In 
order to strengthen policy response it is important to understand what policies have already been 
enacted to address AMR in animals and agriculture. Studies in this dissertation seek to better 
understand national regulatory frameworks to address AMR that have been established in 
countries in Asia.  
Research objectives   
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This dissertation concentrates on two important emerging trends in animal food production 
posing public health and occupational risks. These trends include the increasing use of 
antimicrobials and the re-emergence of a zoonotic disease, brucellosis. Agricultural policies 
influence the expansion of small-scale animal husbandry and impact emergence and re-
emergence of infectious diseases. The goal of this analysis is to understand the role of policy and 
its impact on influencing these two important emerging disease trends. There are four research 
aims in this thesis with each addressed in a chapter.  
Specific Aim 1 
Examine the knowledge, attitudes and livestock practices related to brucellosis 
among small-scale goat farmers. Chapter 2 is a cross-sectional study of small-scale 
farmers in Ratchaburi Province, Thailand.  Farmers’ attitudes, experience and behaviors 
towards brucellosis were measured along with serological testing for brucellosis in goats. 
The purpose of this study is to identify the potential determinants of exposure and 
occupational risk to brucellosis among goat farmers. The hypothesis of this study is that 
small-scale farmers have limited knowledge and awareness of brucellosis and that goat 
farming poses an occupational risk for human infection of brucellosis.  
Specific Aim 2  
Estimate herd and animal level seroprevalence of brucellosis in small ruminants 
in Thailand and determine which regions have the highest rates of infection. Chapter 3 
analyzes national brucellosis surveillance data collected in Thailand from 2013 – 2015. 
The purpose of this study is to estimate national seroprevalence of brucellosis at the 
animal and herd level among small ruminants and to describe the spatial distribution of 
brucellosis throughout the country during a three-year period.  
Specific Aim 3 
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This study identifies policy response to antimicrobial resistance (AMR) and 
analyzes policies related to antimicrobial use (AMU) and resistance from Indonesia, 
Cambodia, Myanmar, Lao PDR and Viet Nam. The purpose of this study is to analyze 
and describe countries’ current regulatory framework to address AMR and AMU. The 
hypothesis of this analysis is that governments in Southeast Asian countries have yet to 
put in place a comprehensive and coherent legal and regulatory framework to protect 
public and animal health from AMR.  
Specific Aim 4 
Qualitative methods were used to analyze twelve countries regulatory 
frameworks to address antimicrobial resistance (AMR) and antimicrobial use (AMU) in 
animals and agriculture. Countries were from South Asia, the Pacific and Southeast Asia. 
This analysis provides information on countries awareness of existing policy to address 
AMR and AMU, future policy plans and overall national regulatory frameworks.  
Significance  
Overall, these studies contribute to our knowledge and understanding of how agricultural, 
health and public policies contribute to a system that can influence emerging trends in animal 
food production, including the spread of infectious diseases. Agriculture policies implemented by 
governments can have a direct and indirect consequence on occupational health risks particularly 
to farmers in low and middle income countries. The first study in this dissertation on brucellosis 
knowledge, attitudes and behaviors provides an example of the risk of the spread of a zoonotic 
disease at the farm level. The second analysis estimates the seroprevalence of brucellosis at the 
animal and herd level among small ruminants to understand how these trends are changing over 
time and by region and the direct impact of agricultural policies in Thailand.  
The last two analysis of this dissertation, Chapters 4 and 5, describe the policy gaps and 
policy solutions, goals and benchmarks for national policies to address antimicrobial use and 
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resistance. The rationale for these analyses is that understanding the consequences of agricultural 
policies provides informed recommendations for public and veterinary health management and 
prevention of diseases such as AMR. Understanding the interaction between agriculture 
legislation and policy, animal husbandry practices and occupational risks is an important step in 
controlling infectious diseases in Southeast Asia and around the world. Research from this 
dissertation highlights some of the challenges of infectious disease prevention and control. 
Studies from this dissertation provide a basis for future studies on agricultural and public policy 
for more effective control efforts for emerging and re-emerging threats in low- and middle-
income countries.  
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Chapter 2:  
Knowledge, attitudes and practices associated with brucellosis among 
small-scale goat farmers in Thailand  
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Summary   
Background 
Brucellosis re-emerged in humans in Thailand in 2003 with most infections occurring in in goat 
farmers. Research reports varying levels of the disease in humans with some estimates as high as 
45.33% seroprevalence in goat farmers (Ekpanyaskul et al., 2012). Limited studies have been 
conducted to estimate seroprevalence of the disease in goats and to better understand farmers 
behaviors and experience with the diseases.  
Methods 
To better understand Thai farmers’ knowledge, attitudes and behaviors associated with 
brucellosis a cross-sectional study was conducted during a three-month period in 2016 and 
included goat farmers living in rural and peri-urban areas of Ratchaburi Province in western 
Thailand. Fifty-one farmers were interviewed using a questionnaire that gathered information on 
demographics, understanding, attitudes and practices related to brucellosis and goat farming.  
Findings 
All serological samples collected from goats tested negative for brucellosis. Most respondents 
had limited experience with goat farming as over half (53%) reported owning goats for five or 
fewer years. The majority (80%) of farmers had heard of brucellosis but had limited knowledge 
of the disease in animals other than in goats, and limited understanding of disease transmission 
and symptoms. Knowledge of human brucellosis was particularly limited with just over half 
(54%) reporting that humans could become infected and less than half correctly identifying a 
symptom of the disease in humans. Participants had a very low perceived risk of infection with 
the majority reporting that they or a member of their household were not at risk of the disease. 
The majority of farmers reported limited use of personal protective equipment with fewer than a 
quarter reporting wearing gloves when in contact with livestock.  
Conclusions 
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This study contributes to a more comprehensive understanding of brucellosis in Thailand by 
identifying specific human risk exposure to the disease through animal husbandry practices. 
Similar to previous research this study found that brucellosis poses an occupational risk as 
farmers engaged in high risk behaviors including minimal use of personal protective equipment 
and taking limited actions to assure a goat was healthy before purchase.  Additionally, this study 
identifies areas where knowledge of brucellosis could be strengthened through farmer education 
and training.  
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Introduction   
Brucellosis poses a significant public health risk in many regions of the world, 
particularly in low and middle income countries (Corbel, 2006). This zoonotic disease is caused 
by bacteria of the genus Brucella (Corbel, 2006; Seleem et al., 2010). The most infectious and 
common species of Brucella is Brucella melitensis (B. melitensis) whose primary animal hosts are 
sheep and goats (Corbel, 2006; Godfroid et al., 2011).  B. melitensis in humans can present mild 
to severe symptoms causing fever, sweating, fatigue, weight loss, headache and joint and muscle 
pain (Corbel, 2006; Dean et al., 2012). The disease poses a significant risk to pregnant women as 
it can cause abortion or intrauterine transmission to the infant (Spink, 1956). In animals, 
brucellosis typically causes reproductive issues including abortion, premature births, decreased 
fertility and retained placenta (Corbel, 2006). Laboratory tests are essential to confirm a case of 
brucellosis in humans and animals as symptoms are varied and often non-specific (Molavi, 2012; 
Corbel, 2006).  Infected animals excrete Brucella in urine, milk, placenta, and the products of 
miscarriage (Laosiritaworn et al., 2007). Typical transmission to humans occurs through direct 
contact with fluids from animals including placentas or aborted fetuses, or consumption of 
infected animal products, primarily non-pasteurized milk products or insufficiently cooked or raw 
meat (Laosiritaworn et al., 2007).  
Literature suggests that expansion of animal husbandry programs and a lack of 
agricultural training and regulation contribute to a re-emergence of brucellosis in different parts 
of the world (Morse, 1995). One country that has experienced a re-emergence of human 
brucellosis is Thailand. There were no reported human cases of the disease in Thailand from 1970 
until 2003 when two cases of B. melitensis in goat farmers were identified (Paitoonpong et al., 
2006; Danprachankul et al., 2009; Chiewchanyont et al., 2011). The current incidence in Thailand 
is between 5 and 11 reported and confirmed human cases per year according to the Thai Bureau 
of Epidemiology National Surveillance System (Thai Bureau of Epidemiology, 2016). Human 
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brucellosis is currently considered endemic to Thailand and one potential contributing factor to 
the re-emergence of brucellosis is the substantial increase in goat farming throughout the country 
(Wongphruksasoong et al., 2009; Nakavisut et al., 2014). Most cases of brucellosis in humans 
occur in goat farmers or are related to exposure to goats (Wongphruksasoong et al., 2009; 
Nakavisut et al., 2014). From 2002 to 2007 the number of registered goats in Thailand has 
increased from 177,944 to 444,744 (Chiewchanyont et al., 2011). In 2014, the Thai Department 
of Livestock Development (DLD), estimated that there were 41,674 goat farmers throughout the 
country (Kanitpun, 2014). The Thai government has promoted goat farming in Thailand through 
agricultural policies that support goat rearing through initiatives such as free insemination and 
vaccination (Nakavisut et al., 2014). Goats in Thailand are primarily used for their meat with 
consumption of goat milk becoming increasingly more popular as well as the use of goat placenta 
in cosmetic products (Anothaisinthawee et al., 2012).  
Despite the re-emergence of brucellosis in Thailand, a limited number of studies have 
been conducted that examine small-scale goat farmers and their knowledge, attitudes and 
practices associated with the disease (Bordier et al., 2013). In 2003, the Thai Bureau of 
Epidemiology with the Thai DLD, investigated human brucellosis cases to identify risk factors 
for infection. Researchers categorized exposure to brucellosis as an occupational risk for goat 
farmers (Thai Bureau of Epidemiology, 2003). In 2009, Thai researchers reviewed human cases 
of brucellosis reported from 2003 to 2008 throughout the country and determined that all but two 
of the cases were associated with exposure to goats (Chiewchanyont et al., 2011). In 2012, 
investigators conducted a study among goat farmers where an outbreak of human brucellosis had 
previously occurred and determined that knowledge and perception of brucellosis was very poor 
and that there is a need for more effective training to prevent the disease in goats and other 
animals (Inchaisri et al., 2012). The objective of this study is to better understand the 
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determinants of exposure to brucellosis associated with goat farming by assessing knowledge, 
attitudes and practices related to brucellosis among small-scale goat farmers.  
Methods  
Study design   
Between June and August 2016, 53 small-scale goat farmers living in rural and peri-
urban areas of Ratchaburi Province, Thailand were recruited to participate in this study. 
Participants recruited for this study were selected from a roster of farms registered with the Thai 
DLD. Inclusion criteria for recruitment were famers who owned 200 or fewer goats, were the 
person primarily responsible for the daily management of the farm and whose households were 
directly on the farm. Of the 53 participants, 51 farms were included that met the inclusion criteria 
and agreed to patriciate. Ratchaburi Province was selected as the study area because it is mostly 
agricultural with a high concentration of small-scale goat farms and is an area where previous 
outbreaks of brucellosis have occurred in goat farmers (Te-chaniyom et al., 2015).  
Study teams included two or more veterinarians, provincial DLD officers and trained 
interviewers. Study teams visited each farm, gathered serological samples from goats and 
conducted interviews with farmers. Prior to participation in this study, respondents were orally 
informed about the research and provided written consent before participation. Approval to carry 
out the study was obtained from the University of Minnesota’s Institutional Review Board and 
Chulalongkorn University’s Ethics Review Committee. Approval for the animal study was 
obtained from Chulalongkorn University and University of Minnesota Institutional Animal Care 
and Use Committees. Additionally, approval was obtained from the DLD.   
Survey methods 
Farmers were interviewed using a 55-item questionnaire gathering information on 
demographics, knowledge, attitudes and practices relating to brucellosis. Questions were adapted 
from several studies assessing attitudes, knowledge and practices related to brucellosis among 
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small-scale farmers (Holt et al., 2011; Montiel et al., 2013). The questionnaire was administered 
orally in the participant’s native language, Thai, by a trained interviewer. Three of the interviews 
were conducted over the phone due to time constraints during the farm visit. Upon completion of 
the interview farmers were given a cash gift (300 Thai Baht). Participant interviews gathered 
information on participant demographics, risk factors, attitudes and knowledge of brucellosis, and 
goat and livestock ownership. Additionally, farmers experience with goat husbandry and barriers 
to the adherence of recommended husbandry practices were measured. Specific risk factors 
measured included grazing system, breeding practices, consumption of goat products and herd 
size. Additional details gathered about the goats included sex, age, and breed. Variables were 
measured as either continuous or categorical. 
Serological testing  
During farmer interviews, serological samples were collected from all goats at 
participating farms to estimate the seroprevalence of B. melitensis through the measurement of 
immunoglobulin G (IgG) antibodies. For identifying samples for testing, 15% of samples were 
randomly selected for testing from farms that had more than ten goats. This estimate was based 
on expected prevalence for the region according to DLD estimates. Samples were randomly 
selected based on codes randomly assigned during farm visits. For herds with less than ten goats 
all samples were tested. Following the World Organisation for Animal Health (OIE) standards, 
serological samples from goats were tested using the Rose Bengal Plate Test (RBPT) and the 
enzyme-linked immunosorbent assays (ELISA) test for Brucella. Serological testing took place at 
Chulalongkorn University Faculty of Veterinary Sciences Diagnostic Laboratories.  
Data analysis    
All data from the survey questionnaires and laboratory results were entered into 
Microsoft Office Excel 2015 (Excel, 2015). Data were analyzed using the statistical package 
STATA 14 (Stata Corporation, College Station TX, 2015). To examine knowledge, attitudes, and 
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practices towards brucellosis to determine how these factors impact knowledge of brucellosis, 
models were run for each independent variable of interest and included multivariate logistic 
regression analysis of risk factors associated with knowledge of brucellosis. For the ELISA test, 
positive and negative controls were used to validate the test following the manufacturer’s 
instructions. Each sample reaction from the ELISA was measured by an ELISA reader to 
determine the optical density (OD) at 450 nanometer. The ratio between the OD value for the 
sample and the OD value for the positive and negative controls were used to determine the S/P 
ratio. Serological samples were interpreted as positive with an S/P ratio greater than or equal to 
120%. For the RBPT, following the manufacturer’s instructions, serum was placed on a well of 
the test kit. An equal amount of antigen was placed on the sample and the mixture was gently 
moved consistently for four minutes and then observed for agglutination. If agglutination was 
observed, the sample was classified as positive, without agglutination the sample was classified 
as negative.  
Results   
Demographic characteristics   
A total of 53 farms were visited during the study period from June to August, 2016. 
Among the 53 farms, 51 farms agreed to participate in the research that met the inclusion criteria. 
Over half (55%) of survey participants sampled were female and the majority (64%) reported 
primary school as their highest level of education completed. The most commonly reported age 
range was between 50-72 years old (51%). Most (63%) respondents reported having between 1 – 
3 children under the age of 18 living at their household. The majority (80%) of respondents 
reported goat farming as their primary occupation and or their primary source of income. Table 2-
1 describes the demographic characteristics of the respondents.  
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Table 2-1. Demographic characteristics of small-scale goat farmers in Ratchaburi Province, Thailand 
reported in a study on the knowledge, attitudes and practices associated with brucellosis in 2016 
(n=51) 
Characteristic  (n) (%) 
Gender  
Male 23 45% 
Female 28 55% 
How many years have you lived in your current village or place of residence?  
10 or less  14 28% 
11 – 30 13 25% 
31 - 51 24 47% 
How old were you at your last birthday?  
25 - 34 6 12% 
35 – 49  19 37% 
50 - 72 26 51% 
How many adults (over the age of 18) are currently living in your household?  
1 – 4  34 67% 
5 – 10  17 33% 
How many children (under the age of 18) are currently living in your household?  
0 18 35% 
1 – 3  32 63% 
4 +  1 2% 
What is your highest level of completed education?   
No education  1 1% 
Primary school  32 64% 
Secondary school  14 27% 
Diploma   2 4% 
Bachelor Degree 2 4% 
Is your primary source of income and or primary occupation farming?  
Yes 41 80% 
No 10 20% 
 
Farm characteristics and livestock practices  
Over half (53%) of the farmers reported owning goats for five or fewer years and the 
average farm size was 31 goats. The majority (86%) of farms reported owning at least one other 
type of animal including chicken (58%) or another type of poultry or both and a quarter (25%) of 
respondents owned cattle. The majority (92%) of farms reported grazing their goats at their 
household property and a third (30%) of respondents reported that they earned money renting out 
at least one of their goats to another farm in the past twelve months. Almost all (92%) 
respondents reported wearing or using at least one piece of personal protective equipment (PPE) 
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when in contact with livestock. The most commonly reported piece of self-described PPE used 
was a long-sleeve shirt (92%). Less than a quarter (24%) of respondents reported wearing gloves 
when in contact with livestock. When asked the primary reason for not using PPE the majority 
(93%) of respondents reported that “there is no need for this equipment”.  
None of the participants reported consuming, selling or bartering meat, dairy or other 
products including placenta, from any of the goats they raised. All respondents reported that the 
primary purpose of their goats was for selling or bartering. When asked where or to whom they 
primarily sold their goats, more than a third (37%) reported selling to a merchant that purchased 
goats directly from their home. Sixty-six percent (66%) of farmers reported selling or bartering 
between 1 – 24 goats in the past 12 months. Over a third (33%) of farmers reported purchasing at 
least one new goat in the past twelve months. When asked where farmers purchased their goats, 
over half (61%) reported purchasing from a local market. See Table 2-2 for further details on 
farm characteristics and livestock practices.  
Table 2-2. Farm characteristics and livestock practices among small-scale goat farmers in Ratchaburi 
Province, Thailand (n= 51) 
Characteristic (n) (%) 
How many years have you owned goats?   
1 - 5 27 53% 
6 - 10   23 45% 
11 +  1 2% 
How many goats do you own?  
1 – 10 15 29% 
11 – 20  15 29% 
21 - 50 13 26% 
51 - 200 8 16% 
Where do you primarily graze your livestock?   
Household property 47 92% 
Neighbors property  3 6% 
Communal grazing land  1 2% 
How many goats did you sell or barter in the past 12 months? (n=48)   
1 – 24 32 66% 
25 – 49  10 21% 
50 - 100 6 13% 
If yes, where or to whom do you primarily sell your livestock to? (n=51)  
Local market  10  20% 
Market in neighboring villages 2 4% 
Livestock auction 1 2% 
Relatives / friends / neighbors 19  37% 
Merchant that purchases direct from home  19 37% 
When you purchase goats, where do you purchase them from? (n =51)  
Local market 31 61% 
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Market in neighboring village 11 22% 
Relative or friends 7 13% 
Merchant  1 2% 
Provincial Livestock Office 1 2% 
During contact with livestock do you use the following protective equipment and or 
procedures?  (n=47) Check all that apply 
Boots 42 82% 
Pants 26 51% 
Long sleeve shirt 47 92% 
Avoid drinking or eating  27 53% 
Protective mask  37 73% 
Gloves 12 24% 
Goggles  3 6% 
 
Goat health, treatment and prevention practices  
Respondents were asked about their treatment and prevention practices specific to goat 
farming (Table 2-3). Almost all (90%) of participants reported that when they purchase a new 
goat they take actions to assure that the animal is healthy. Among those who reported taking 
actions when purchasing a new goat, almost a third (28%) reported that they require laboratory 
testing to make sure that the animal is healthy, almost a quarter (23%) require veterinary 
inspection and almost half (47%) rely on their own experience and judgement to determine if the 
goat is healthy. Less than a quarter (15%) of farmers reported quarantining the animal when they 
purchase a new goat. When asked what farmers do when a goat displays any signs of illness or 
disease, the majority (82%) of respondents give their goat(s) antibiotics and over half (53%) seek 
veterinary assistance. For the purposes of this study the Thai definition of a veterinarian was used 
which defines a vet as a licensed professional with a degree in veterinary medicine from an 
accredited institution.  
Among respondents that do not seek veterinary assistance when a goat shows signs of 
illness or disease, the majority (96%) report that they do not believe this is necessary because 
they rely on their own personal experience and knowledge to treat the goat and the rest (4%) 
report not seeking veterinary assistance because the cost is too high. When asked how often 
respondents give antibiotics to their goats the majority (78%) report giving antibiotics to goats 
once a year while fewer than a quarter (18%) of respondents give antibiotics to their goats daily. 
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Almost all (96%) farmers reported that they did not give antibiotics to their goats when they are 
healthy. Seventy-five percent (75%) of respondents purchased their antibiotics at a pharmacy for 
animals, while less than a quarter (17%) purchased or were given antibiotics from a veterinarian. 
Two respondents reported that at least one of their goats had an abortion and or stillbirth in the 
last twelve months and both respondents reported burying the livestock fetuses. The majority 
(84%) of respondents reported burying their livestock carcass when an animal dies from illness. 
None of the 314 goat samples tested positive for B. melitensis for either the ELISA test for 
Brucella or the RBPT.  
Table 2-3. Goat health, treatment and prevention practices among small-scale goat farmers in 
Ratchaburi Province, Thailand (n=51)  
Characteristic  (n) (%) 
When you purchase or are given a new goat what action(s) do you take to assure that the goat is 
healthy? (n=47) Check all that apply 
Trust in own experience and judgment 22 47% 
Require laboratory tests 13 28% 
Veterinary inspection 11 23% 
Quarantine 7 15% 
Sought expertise from experienced people in village 4 8% 
Bought animals from persons you trust have healthy animals 4 8% 
Paperwork indicated animal as healthy 2 4% 
Inspection from seller 1 2% 
What do you do if a goat is sick and/or shows signs of disease? (n=51) Check all that apply 
Seek veterinary assistance 27 53% 
Treat according to personal knowledge and experience 16 31% 
Seek advice from friend/neighbor/ family 4 8% 
Slaughter 0 0% 
Isolate the animal  5 10% 
Sell the goat 1 2% 
Give the goat antibiotics 42 82% 
When you use antibiotics, how often do you give them to your goats? (n=51) 
Daily 9 18% 
Weekly  1 2% 
Monthly  1 2% 
Once a year  40 78% 
Where do you purchase and/or are given antibiotics from? (n=43)  
Veterinarian 7 17% 
Pharmacy for humans 3  6% 
Pharmacy for animals  32 75% 
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Friends or neighbors  1 2% 
 
Brucellosis knowledge and experience among farmers 
The majority (80%) of respondents had heard of brucellosis. Among those who had heard 
of brucellosis more than a third (39%) reported learning about the disease from relatives or 
friends or both and the majority (98%) identified that goats were susceptible to brucellosis. Forty-
one percent (41%) reported that cattle could become infected and 44% reported that sheep were 
susceptible to brucellosis. Over half (57%) reported that animals become infected with brucellosis 
through contact with aborted fetuses and placenta and all respondents who had heard of 
brucellosis correctly identified at least one symptom of the disease in animals. The majority 
(69%) reported that abortion was a symptom of brucellosis in goats and over half (53%) 
identified that decreased production could occur as a result of the disease in goats.  
Among respondents aware of brucellosis, a little over half (54%) reported that humans 
could become infected. Over half (61%) reported that humans become infected through direct 
contact with livestock fetuses or fluids from infected animals. More than a third (38%) reported 
that they didn’t know or were unsure if humans could become infected with brucellosis through 
mosquito bites and more than half (56%) reported that humans could not become infected by 
consuming unpasteurized (non-boiled) milk. Over half (58%) of respondents also did not believe 
humans could become infected by consuming undercooked or raw meat. Less than half (44%) of 
respondents could correctly identify at least one symptom of brucellosis in humans. See Table 2-4 
for more information on respondents’ knowledge of brucellosis. To estimate potential predictors 
of knowledge of brucellosis (such as has the farmer heard about brucellosis), univariate logistic 
regression analysis was used. Explanatory variables included gender, level of education, number 
of goats, years of farming, age and primary occupation. No association was found between 
knowledge of brucellosis and any of the predicator variables investigated.  
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Table 2-4. Knowledge of brucellosis among small-scale goat farmers in Ratchaburi Province, 
Thailand (n=51)  
Characteristic  (n) (%) 
Who or what is your primary source of information about brucellosis? (n=41) Check all that 
apply 
Relative and or friend 16 39% 
Veterinarian 13 31% 
Book 10 24% 
Radio  1 2% 
Internet 0 0% 
Village livestock meeting   12 29% 
Which animals can become infected with brucellosis? (n=41)  
Cattle  17 41% 
Sheep  18 44% 
Goats  40 98% 
Dogs  11 22% 
Cats  10 20% 
How do animals become infected with brucellosis? (n=41) 
Contact with urine or other bodily fluids from 
infected animal  
11 27% 
Licking infected animals  3 7% 
Sharing a space with infected animals 7 17% 
Contact with aborted fetuses and placentas  23 57% 
Which of the following are symptoms of brucellosis in animals? (n=41) 
Abortion  28 69% 
Premature births  4 10% 
Swollen udders  1 3% 
Swollen testicles  7 17% 
Fever  16 39% 
Retained placenta  1 2% 
Infertility  11 27% 
Decreased production  22 54% 
Can humans become infected with brucellosis? (n=41) 
No 17 41% 
Yes 22 54% 
Don’t know/unsure 2 5% 
If yes, how do humans become infected from an animal?  
Consuming unpasteurized (non-boiled) milk? 
(n=36) 
2 6% 
Consuming undercooked or raw meat (n=36)  1 3% 
Contact with infected livestock fetuses and fluids 
from infected animals? (n=36) 
22 61% 
What are the symptoms of brucellosis in humans?  
Fever (n=40)  17 42% 
Arthritis (n=41)  4 10% 
Aches (n=41)  4 10% 
Chills (n=41)  2 5% 
Joint and back pain (n=40) 1 2% 
Sweats (n=41)  1 3% 
 
Experience and attitudes associated with brucellosis  
None of the respondents reported that they or any member of their household had ever 
been told by a doctor that they had brucellosis. Only one respondent reported having a case of 
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brucellosis in at least one of their goat(s). The respondent reported that this case was confirmed 
and treated by a veterinarian. The respondent did not report culling the goat or having other 
livestock tested for the disease after the goat(s) was diagnosed with brucellosis. The majority 
(91.7%) of respondents do not believe they or any member of their household is at risk of 
brucellosis. Over half (62.5%) do not believe they are at risk of the disease because of safe farm 
practices. The majority (82%) believe that if one of their goats had brucellosis it would be quite 
serious and almost all (97.6%) respondents would like more information on the disease.  
Discussion  
Since the early 2000s the Thai government has promoted the expansion of small-scale 
goat farming through agricultural policies that encourage goat rearing (Nakavisut et al., 2014). 
These policies have contributed to an increase in goat farms throughout Thailand with a 
substantial number of new farmers entering the field of goat farming (Nakavisut et al., 2014; 
Anothaisinthawee et al., 2012). Although goat farming is a new occupation to them, for most it is 
their primary occupation and only source of income (Laosiritaworn et al., 2007; Chiewchanyont 
et al., 2011).  This is significant when considering the importance of the goats’ and farmers’ 
health. Similar to previous research, this study found that brucellosis poses a potential 
occupational risk to goat farmers in Thailand (Laosiritaworn et al., 2003; Chiewchanyont et al., 
2011; Anothaisinthawee et al., 2012). None of the respondents in this study reported consuming 
any products from their goats indicating that exposure to brucellosis could occur through other 
modes of transmission such as direct contact with fluids from animals rather than through 
consumption of milk or meat products (Chiewchanyont et al., 2011).  
Farmers reported limited use of PPE when in contact with livestock. Limited use of PPE 
can be problematic as researchers have identified unprotected contact with placenta, blood and 
secretion as high risk factors for exposure to B. melitensis in Thailand (Thai Bureau of 
Epidemiology, 2003). However, use of PPE during high-risk situations such as during an disease 
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outbreak or during birthing should be emphasized. In the US and Canada, goat farmers are 
encouraged to implement biosecurity efforts including use of PPE. Recommended PPE includes 
appropriate, clean and farm-specific outerwear and footwear for use when in contact with 
livestock. During an infectious disease outbreak farmers are recommended to wear plastic boots, 
gloves and coveralls, as well as fitted masks (Canadian Food Inspection Agency, 2013).  
All farms included in this study housed goats and other animals on their immediate 
household property with very close proximity to households. This poses a potential risk for 
household members to come in contact with infected fluids from goats. Other high risk behaviors 
include not isolating an animal when it shows signs of illness or disease, renting out goats to 
neighboring farms and taking minimal action to assure a goat is healthy when purchasing a new 
animal. Farmers report that they often rely on their own experience and judgement to determine if 
an animal is healthy when purchasing a new goat with very few farmers requiring lab test or 
quarantining the new animal. This finding indicates that education for farmers on veterinary 
inspection, laboratory testing, and quarantine practices when purchasing a new goat might be 
useful in preventing the spread of brucellosis. Just over half of the farmers interviewed reported 
seeking veterinary assistant when their animal was sick while the majority (82%) responded that 
the first course of action to a sign of illness or disease in goats is to self-administer antibiotics to 
the goat. Potential overuse of antibiotics was also demonstrated with almost 20% of farmers 
reporting that they give their goats antibiotics daily. These findings demonstrate that education on 
responsible antibiotic use would be beneficial for this population.  
Similar to previous research, this study found that although most farmers had heard of 
brucellosis, their knowledge of the disease was quite limited (Thai Bureau of Epidemiology, 
2003).  Most farmers identified that goats are susceptible to the disease but were less informed 
about other species susceptibility to brucellosis. Knowledge of human infection was less 
understood among farmers with just over half of respondents reporting that humans can become 
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infected. Respondents demonstrated limited knowledge about how the disease is transmitted from 
animals to humans and had limited awareness of symptoms of the disease in humans. Over half of 
respondents did not believe humans could become infected by consuming undercooked or raw 
meat and less than half of respondents could correctly identify at least one symptom of 
brucellosis in humans. Like previous research conducted in other countries, the majority of 
respondents had low perceived risk of brucellosis infection in themselves or a member of their 
household (Lindahl et al., 2015). Farmers reported that they did not believe they are at risk 
because they have safe farm practices. Only one respondent reported having a confirmed case of 
brucellosis in at least one of their goat(s). This respondent reported that a veterinarian treated the 
goat and did report culling the animal or having other livestock tested for the disease. This 
finding suggests that additional education for veterinarians on best practices for management of 
brucellosis would be appropriate.  
There is a need for more effective training to prevent the disease in goats and other 
animals and almost all the respondents in this study reported that they would like more 
information about the disease (Inchaisri et al., 2012). Farmer education and training on 
brucellosis including knowledge of disease transmission and symptoms in humans would be 
valuable. The most commonly reported source of information about brucellosis was from 
relatives or friends or both suggesting that interventions targeting peer education or goat farming 
networks could be effective at disseminating information about brucellosis.  
Limitations 
The sampling design used for identifying farms poses a limitation to this study. Farms 
were not randomly selected but rather identified based on routine DLD brucellosis testing. A 
selection bias may have occurred with the selected farms as they are all registered farms with the 
Thai DLD and may not be representative of the population of goat farms in Thailand. It is likely 
that the underrepresented farms are farms with few goats, thus routine animal husbandry practices 
  
30 
may differ. This selection may also not be representative of the true seroprevalence of brucellosis 
in goats in Ratchaburi Province. Other issues inherent to this study include issues such as bias due 
to social desirability and relying on self-reported data gathered from the questionnaire.   
Conclusions 
This cross-sectional study contributes to a more comprehensive understanding of the 
knowledge, attitudes and practices associated with brucellosis among small-scale goat farmers in 
Thailand. Findings from this study support that brucellosis poses an occupational risk to goat 
farmers as farmers engage in high risk behaviors. Limitations in knowledge of the disease include 
limited awareness of disease transmission to humans and other species and lack of knowledge on 
safe farm practices such as quarantine practices when purchasing a new animal. Training on safe 
farm management practices, such as the use of PPE, is critical as the incidence of brucellosis and 
other infectious zoonotic diseases are influenced by farmers’ experience, grazing practices, 
importation of animals, and the use of PPE (Lindahl et al., 2015). Prevention of the disease is 
particularly important in resource poor areas as treatment for human cases is expensive and often 
limited (Addis et al., 2015; Perry et al., 2002). Findings from this study are relevant for Thailand 
for improving the national brucellosis control program. Farmers expressed an interest in learning 
more about the disease. A unified approach that would involve both public health and veterinary 
sections would be beneficial realizing that brucellosis poses a health risk for both animals and 
humans.  
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Chapter 3  
 
Seroprevalence of Brucellosis in Goats and Sheep in Thailand: Results 
from the Thai National Brucellosis Surveillance System from 2013 – 
2015  
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Abstract 
 
Brucellosis, a bacterial zoonotic disease, is commonly found in small ruminants in many 
parts of the world (Seleem et al., 2010; Corbel, 2006). The disease poses a public health risk in 
Thailand where it is endemic in small ruminants (Laosiritaworn et al., 2007; Thai Bureau of 
Epidemiology, 2003; Paitoongpong et al., 2006). In 1997 the Thai Department of Livestock 
Development (DLD) established a nationwide surveillance system for brucellosis in goats and 
sheep. We describe the seroprevalence of brucellosis in small ruminants in Thailand using these 
national surveillance data from 2013 – 2015. During the three-year period, 443,561 goats and 
sheep were tested for brucellosis by the DLD throughout Thailand using the Rose Bengal Plate 
Test (RBPT) and the enzyme-linked immunosorbent assay (ELISA) test for Brucella. 
Surveillance data collected included the number of animals and herds tested, the province of the 
animal and herd, and the laboratory results. Seroprevalence was estimated at both the animal and 
herd level. Overall, there was a decrease in the proportion of animals and herds that tested 
positive for Brucella. During the three-year period, 2013 had the highest proportion of herds that 
tested positive for brucellosis at 13.80% (95% CI, 12.52, 15.16).  Provinces in the eastern and 
western regions of Thailand had the highest proportion of animals and herds testing positive 
during all three years and provinces in the south had the lowest. Periodic review of surveillance 
data documents the impact of the current brucellosis control program and supports a targeted 
response in higher prevalence regions when there are limited financial resources for control 
measures. 
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Introduction  
 
Brucellosis, one of the most common zoonotic diseases, poses an occupational risk to 
livestock farmers in many parts of the world (Dean et al., 2012; Perry et al., 2002; Godfroid et al., 
2011). This bacterial disease, also commonly referred to as undulant fever, Malta fever, Crimean 
fever, and Mediterranean fever, is caused by bacteria of the genus Brucella (Corbel, 2006). There 
are several known Brucella species some of which are pathogenic to humans. The most common 
Brucella species are Brucella melitensis, Brucella abortus, Brucella suis, and Brucella canis 
(Corbel, 2006). The most severe and common Brucella species in humans is Brucella melitensis 
(B. melitensis) whose primary animal hosts are sheep and goats (Godfroid et al., 2011).  B. 
melitensis is most commonly spread between animals and to humans through direct contact with 
fluids from infected animals in birthing products and other bodily fluids such as urine (Corbel, 
2006). Brucellosis is considered an occupational disease for those who work with animals 
generally from direct contact with contaminated birth fluids. Transmission to humans is primarily 
through consumption of un-pasteurized dairy products especially raw milk, soft cheeses, and 
butter (CDC, 2017; Corbel, 2006).  
Common symptoms of B. melitensis in animals include abortions, stillbirths, infertility 
and decreased production (Corbel, 2006). Infection in humans can cause a range of symptoms 
common to febrile illness including joint and muscle pain, sweating, headache, fatigue and weight 
loss (Spink, 1956). The disease poses a significant risk to pregnant women as it can cause 
abortion or be transmitted to the infant in utero (Spink, 1956). The disease can additionally 
contribute to chronic illness and disability. (Addis, 2015, Perry, 2005). Severe cases of brucellosis 
in humans can result in endocarditis (Spink, 1956). Brucellosis is ranked as one of the top ten 
animal diseases of concern to impoverished rural communities (Perry, 2005).  
There is increasing concern for the risk of brucellosis globally as the disease is re-
emerging in certain countries where livestock production is increasing (Perry, 2002). Brucellosis 
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is of concern in Thailand where the disease re-emerged in humans in 2003 (Laosiritaworn, et al, 
2007). Two cases of B. melitensis in goat farmers were reported in Thailand in 2003 for the first 
time since the early 1970s (Laosiritaworn, et al, 2007; Chiewchanyont, et al., 2011). Brucellosis 
is considered endemic to Thailand and human and animal brucellosis are notifiable diseases 
(Chiewchanyont, et al., 2011). Understanding seroprevalence in small ruminants is important as 
research indicates that goats play a significant role in transmission of the disease to humans in 
Thailand. Paitoonpong et al. presented a case analysis of seven laboratory confirmed human cases 
of brucellosis in Thailand between 1970 and 2005 and determined that the majority of infections 
were a result of direct contact with goats (Paitoonpong et al. 2006). In 2003, the Thai Bureau of 
Epidemiology (BOE) with the Thai Department of Livestock and Development (DLD) 
investigated human brucellosis cases and categorized exposure to brucellosis as an occupational 
risk for goat farmers (Thai Bureau of Epidemiology, 2003). In 2009, Thai researchers reviewed 
38 human cases of brucellosis reported throughout Thailand from 2003 to 2008 and found that all 
but two of the reported cases were associated with goats and one case was associated with contact 
with sheep (Chiewchanyont et al., 2011).  
One potential contributing factor to the re-emergence of brucellosis has been the 
substantial increase in goat farming throughout Thailand (Nakavisut., 2014). Since the early 
2000’s the number of registered goat farms has more than doubled and continues to increase 
(Kanitpun et al., 2014). The increase in goat farming is partly due to government support for 
small-scale goat farming through agricultural policies that promote goat rearing (Srinoy et al., 
1999; Nakavisut et al., 2014). Policies to encourage goat farming were created in part to increase 
Muslim food production with goat farming originating in only a few select provinces in the south 
(Satchaphun et al., 2014; Nakavisut et al., 2014). Goat farming has since expanded beyond the 
southern region and now occurs throughout Thailand with most farmers raising goats for their 
meat with goat milk becoming increasingly popular (Anothaisinthawee et al., 2012).  
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Additionally, goat farming was promoted as a profitable means to supplement household income 
for low-income farmers. Goat farming is common throughout low- and middle-income countries 
because of their low maintenance costs and grazing habits of poor arable lands (Devendra et al., 
2013).  
Since 2003 the Thai DLD has initiated several programs to control and prevent 
brucellosis in small ruminants (Ninprom et al., 2016). Activities include farm certification 
programs, free brucellosis testing, education and awareness campaigns, regulations to promote 
strict animal movement, policies for testing and slaughtering, and compensation schemes by the 
DLD (Sagarasaeranee et al., 2016; Nakavisut et al., 2014). The DLD policy for positive 
brucellosis tests includes culling the animal and testing the remaining animals in the herd every 
two months until three consecutive negative test results (Sagarasaeranee et al., 2016). Six months 
following the last negative test, the farm can be declared brucellosis free (Sagarasaeranee et al., 
2016). In 1997, the DLD established a surveillance system for brucellosis for goats and sheep in 
Thailand. This system uses serological samples collected during annual brucellosis testing by the 
DLD at registered farms. 
Despite the re-emergence of brucellosis in Thailand, a limited number of studies have 
been conducted that examine seroprevalence in small ruminants. Most research on seroprevalence 
has been concentrated to specific regions of the country. For instance, Ninprom et al., estimated 
seroprevalence of goats in the five most southern provinces of Thailand using data collected in 
2014 from 15,281 goats from 845 herds (Ninprom et al., 2014).  Ninprom et al. estimated herd 
level prevalence at 1.78% and animal level prevalence 0.44% (Ninprom et al., 2014). In 2008, 
Kaewket estimated seroprevalence of brucellosis at 11.5% in goats in the western region of 
Thailand (Kaewket, 2008). One study examined seroprevalence throughout Thailand and 
estimated prevalence at 12.1% (438/3,626) at the herd level and 1.4% (1,297/94,722) at the 
animal level (Sagarasaeranee et al., 2013). Using data from the national brucellosis surveillance 
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system, this study reviews national seroprevalence at the animal and herd level among small 
ruminants and describes the spatial distribution of brucellosis throughout Thailand during a three-
year period. An investigator led study of brucellosis in conjunction with the Department of 
Livestock Development (DLD) was also conducted in Ratchaburi province. The focus of this 
study is on seroprevalence in goats and sheep as these are the primary causes of brucellosis in 
humans in Thailand with as high as 80% of all human cases related to exposure to goats 
(Chiewchanyont et al., 2011). Ruminants and other animals can shed Brucella throughout their 
lifetime.  
Methods 
This study used sample results collected for the Thai National Surveillance System. The 
surveillance system includes test results from annual DLD brucellosis testing among sheep and 
goats at all registered farms for all small ruminants older than six months. Farms voluntarily 
register for brucellosis testing with the DLD, a department under the Thai Ministry of 
Agriculture. The DLD also provided population level data on the total number of goat and sheep 
herds available for testing throughout Thailand. This data includes both registered and non-
registered farms with the DLD.  
An investigator led seroprevalence study was conducted in Ratchaburi Province in 
western Thailand in 2016. This surveillance was part of another effort and is included in this 
analysis as a second source of information on brucellosis seroprevalence. The study tested 314 
goats at 51 registered farms selected by the DLD. A serological sample was collected from every 
goat during the farm visits. For serological testing, 15% of samples from each farm were 
randomly selected for analysis from farms that had ten or more goats based on expected 
prevalence for the region from previous DLD estimates.  For farms that had fewer than ten goats 
all samples were tested. Blood samples were tested at the Chulalongkorn University, College of 
Veterinary Diagnostic Laboratory. Additionally, serological samples tested by the DLD at a 
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regional laboratory during the same timeframe and in the same province were obtained and 
compared. Serological testing followed the same DLD testing protocol at both laboratories. 
Approval to conduct this analysis was obtained from the University of Minnesota Institutional 
Animal Care and Use Committees and the Thai DLD.   
Testing methods for laboratory serodiagnosis of brucellosis used by the DLD include the 
Rose Bengal Plate Test (RBPT) and enzyme-linked immunosorbent assay (ELISA) test for 
Brucella. The ELISA has a 98% sensitivity and 100% specificity and is a direct method for 
detection of specific antibody and therefore it is not prone to a false positive reaction. The RBPT 
is currently the recommended rapid screening test for Brucella with 100% sensitivity and 94.2% 
specificity.  
All samples included in the surveillance system were analyzed at a DLD regional 
laboratory. An animal was considered Brucella positive if either the RBPT or the ELISA test was 
positive. A herd was defined as infected if it had at least one positive animal sample. The term 
‘herd’ is defined by the DLD as a group of animals owned by the same farmer(s). To characterize 
prevalence across the country provinces were divided into six regions used by DLD; south, 
central, western, eastern, northern and northeastern regions. 
Brucellosis prevalence at the herd and animal level was characterized by province and 
region. The precision of the prevalence estimates are described with 95% confidence intervals. 
The spatial distribution of brucellosis seroprevalence was further described at the provincial level 
for all three years using ArcMap 10.5 and is based on digital national maps of Thailand (ESRI, 
Redlands, CA). In these presentations the prevalence is presented as quartiles based on the 
prevalence distribution for all three years across the country. To characterize the relationship of 
brucellosis prevalence between regions and by year, herd-level prevalence rate ratios and 95% 
confidence intervals were estimated with Poisson regression. In these models the estimates were 
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mutually adjusted for year and region. All analyses were completed using the statistical package 
STATA 14 (Stata Corporation, College Station TX, 2015).  
Results  
The DLD tested a total of 443,561 serum samples collected from sheep and goats from 
10,843 herds between 2013 and 2015. Three thousand one hundred and seventeen (3,117) animals 
and 1,010 herds were identified as seropositive during the three year period. Samples were 
collected from 76 provinces in Thailand and the number of samples collected accounts for 27.3% 
of the total small ruminant population and 7.79% of the total small ruminant herd population. In 
2013, the proportion of all goat and sheep that tested positive at the individual animal level was 
1.39% (95% CI, 1.32, 1.46), 0.20% (95% CI, 0.01, .0.20) in 2014, and 0.81% (95% CI, 0.77, 
0.86) in 2015. Nationwide, the proportion of positive herds in 2013 was 13.80% (95% CI, 9.86, 
12.26), 8% (95% CI, 7.41, 9.23) in 2014 and 7.47% (95% CI, 6.72, 8.27) in 2015.  
The seroprevalence for the entire country and all years at the animal level was 0.72% 
(95% CI, 0.68, 0.73) and 9.31% (95% CI, 8.77, 9.88) at the herd level. Provinces in the southern 
region of the country had the lowest proportion of animals testing positive for brucellosis 
compared to other parts of Thailand with an overall herd level seroprevalence of 2.93% (95% CI 
2.4, 3.5) and .31% (95% CI .27, .34) animal level seroprevalence. Our estimates indicate that 
overall seroprevalence among provinces ranged from 0.31% (95% CI, .27%, .34%) to (1.12, 95% 
CI, 0.89%, 1.39%) at the animal level and 2.92% (95% CI, 2.44%, 3.5%) to 18.42% (95% CI, 
1.32%, 2.47%) at the herd level. The seroprevalence of brucellosis at the animal and herd level is 
summarized by year and by region in Tables 3-1 and 3-2.  
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Table 3-1. Seroprevalence of brucellosis in sheep and goats at the animal level, by 
region in Thailand, 2013 – 2015  
Region Year Animals tested 
Positive 
animals 
Animal 
seroprevalence  
Northern 2013 2482 3 0.12% 
Northeastern 2013 6093 95 1.56% 
Central 2013 18734 380 2.03% 
Eastern 2013 1400 22 1.57% 
Western 2013 45050 716 1.59% 
Southern 2013 29621 220 0.74% 
Total 2013 103,380 1,436 1.27% 
Northern 2014 3920 2 0.05% 
Northeastern 2014 4488 3 0.07% 
Central 2014 34653 96 0.28% 
Eastern 2014 2733 21 0.77% 
Western 2014 98972 202 0.20% 
Southern 2014 30806 21 0.07% 
Total  2014 175,572 345 0.20% 
Northern 2015 4401 23 0.52% 
Northeastern 2015 7613 79 1.04% 
Central 2015 36877 331 0.90% 
Eastern 2015 2890 36 1.25% 
Western 2015 71993 793 1.10% 
Southern 2015 40835 74 0.18% 
Total  2015 164,609 1,336 0.82% 
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Table 3-2. Seroprevalence of brucellosis in sheep and goats at the herd level, by region in 
Thailand, 2013 – 2015  
Region Year Herds tested Positive herds Herd 
seroprevalence 
Northern 2013 36 2 5.56% 
Northeastern 2013 190 35 18.42% 
Central 2013 488 79 16.19% 
Eastern 2013 33 10 30.30% 
Western 2013 949 169 17.81% 
Southern 2013 999 77 7.71% 
Total 2013 2,695 372 13.80% 
Northern 2014 60 1 1.67% 
Northeastern 2014 91 2 2.20% 
Central 2014 742 82 11.05% 
Eastern 2014 76 13 17.11% 
Western 2014 1502 181 12.00% 
Southern 2014 1150 21 2.00% 
Total 2014 3,621 300 8.29% 
Northern 2015 81 5 6.17% 
Northeastern 2015 211 23 10.90% 
Central 2015 699 74 10.59% 
Eastern 2015 81 12 14.81% 
Western 2015 1299 169 15.09% 
Southern 2015 2156 28 1.30% 
Total 2015 4,527 338 7.47% 
 
Regional differences as a risk factor for brucellosis infection were investigated. A 
multivariable Poisson model with robust standard errors was used to model the count of Brucella 
positive animals and herds, with the number of herds and animals tested as an exposure variable 
and adjusted for year. Both model’s pseudo r^2 suggests the fit was appropriate with values 
between 0.2 – 0.4 (McFadden, 1974). The year, 2013 was used as the reference group for the 
variable year. Due to its low seroprevalence at the herd and animal level the southern region was 
included as the reference group. Compared to the south, differences in seroprevalence were 
statistically significant for the western, eastern and central regions for the herd level 
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seroprevalence. After controlling for year, herds in the eastern region had 2.34 times the 
prevalence of brucellosis compared to the southern region. For the animal level seroprevalence, 
the eastern, central and northeastern regions were statistically and nearing statistical significance 
different compared to the southern region.  
 
Table 3-3. Prevalence ratios of animal seropositivity by region   
Region  
Prevalence 
ratio   
95% CI  
2013 1 - 
2014 .13 (.09, .20) 
2015  .58 (.41, .82) 
Southern  1 - 
Northern 0.41 (0.17, .94) 
Northeastern 1.30 (0.96, 1.76) 
Central 1.46 (0.94, 2.28) 
Eastern 1.87 (1.23, 2.82) 
Western 1.39 (0.86, 2.24) 
 
 
Table 3-4.  Prevalence ratios of herd seropositivity by region   
Variable  
Prevalence 
ratio   
95% CI  
2013 1 - 
2014 0.50 (.31, .79) 
2015 0.47 (.28, .78) 
Southern 1 - 
Northern 0.56 (0.29, 1.05) 
Northeastern 1.31 (0.83, 2.04) 
Central 1.44 (0.99, 2.09) 
Eastern 2.34 (1.59, 3.44) 
Western 1.72 (1.11, 2.67) 
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 Spatial distribution of brucellosis is shown in Figures 2-1 and 2-2. Provinces in the 
eastern region of Thailand had on average the highest proportion of herds testing positive during 
a 3-year period. The second highest animal and herd level seroprevalence were detected in the 
western region. The western region had a herd level seroprevalence of 17.81% and an overall 
herd level seroprevalence of 13.84% in 2013 (see Table 3-2). Among provinces that had greater 
than ten herds, Kanchanaburi Province, in the central region of Thailand, had the highest 
proportion of herds that tested positive for brucellosis at 59.78% (95% CI, 49.04, 69.87) in 2013. 
The province with the highest proportion of animals testing positive at the individual animal level 
was Phichit, in the northern region, with 30.64% (95% CI, 24.8, 36.96) in 2013. This finding 
suggests that a substantial proportion of goat and sheep herds in these regions were actively or 
recently infected. 
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Fig. 2-1. Spatial distribution of the proportion of goats and sheep who tested positive for brucellosis at the animal level, Thailand, 2013 - 2015.  
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Fig. 2-2. Spatial distribution of the proportion of goats and sheep who tested positive for brucellosis at the herd level, Thailand, 2013 - 2015.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013 2014
  
2015 
  
  
45 
Province specific findings from the investigator study conducted in 2016 in Ratchaburi 
Province found varying results. Laboratory confirmed results from Chulalongkorn University 
veterinarian laboratory tested 314 samples and found all to be negative. The Thai DLD tested 119 
samples collected during the same time-period and the same region and confirmed 4 tests to be 
positive estimating the proportion of positive goats to be 3.36% (95% CI, 0.92, 8.38).  
Discussion 
 
Using data from the Thai national brucellosis surveillance system, this study aimed to 
estimate the proportion of small ruminants that tested positive for Brucella at the animal and herd 
level from 2013 to 2015. This analysis indicates that overall the proportion of positive brucellosis 
cases is decreasing throughout the country at both the animal and herd level. These findings are 
consistent with previous research conducted by the DLD indicating that brucellosis in small 
ruminants is decreasing in Thailand (Sagarasaeranee et al., 2016). However, the high proportion 
of herd level seropositivity among the three-year period in the eastern and western regions 
suggest that prevention and control efforts could be enhanced in these areas for more effective 
brucellosis control. Provinces in the central region also experienced a high proportion of herds 
that tested positive. These are areas of concern as provinces in this region such as Kanchanaburi 
Province have previously experienced human brucellosis outbreaks (Sagarasaeranee et al., 2016; 
Danprachankul et al., 2009). Estimates from the western region are similar to Kaewket’s findings 
from 2008 with 11.5% at the herd level compared to our herd level seroprevalence of 13.84% 
(Kaewket et al., 2008). 
On average, farms in the southern provinces had the lowest seroprevalence at both the 
herd and animal level. It is worth noting that our results are comparable to previous research 
estimating seroprevalence in southern provinces. Our estimates are similar to Ninprom et al. who 
estimated seroprevalence at 0.44% at the animal level and 1.78% at the herd level in the south. 
However, this analysis contradicts previous research that identified the southern region of 
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Thailand as an area of high concern for brucellosis due to shared borders and high goat meat 
consumption (Baimiya et al, 2015; Ninprom et al., 2014).  
Serological findings from province specific seroprevalence studies in Ratchaburi 
Province, were to be expected given the sample size. In 2015, the DLD tested 15,377 animals 
from 482 farms from this region and found a 0.66% seroprevalence at the animal level and 7.26% 
seroprevalence at the herd level. Ratchaburi Province overall had an average herd level 
seroprevalence of 8.87% and .70% animal level seroprevalence from 2013 - 2015. Ratchaburi 
Province has a high concentration of goat farms with nine out of ten districts in the province 
having goat farms (Te-chaniyom et al., 2015). This is also a province of concern as previous 
human brucellosis cases associated with goats have been detected in this region (Te-chaniyom et 
al., 2015).   
The surveillance data demonstrate that the number of farms tested increased throughout 
Thailand from 2013 – 2015. For instance, the number of herds tested among all regions, more 
than doubled from 1,754 in 2013 to 4,572 in 2015. Provinces in the central and western regions of 
Thailand had the highest number of goats and sheep tested throughout the country with Nakhon 
Pathom, Ratchaburi and Kanchanaburi having the highest numbers of animals and herds tested 
from 2013 – 2015. Population level farm and animal data also indicate that goat and sheep 
farming is increasing throughout Thailand. The sheep and goat population increased 22.85% from 
476,513 animals in 2013 to 585,387 in 2015. The number of herds increased by 2.64% during this 
time period indicating that the number of farms is not increasing at a high rate but rather 
individual farms maybe increasing the number of goats and sheep. The population level data 
indicate that the southern and western regions of Thailand have the highest number of goats and 
sheep among all the regions.  
As goat farming continues to increase, potential human health consequences should be 
taken into consideration when adapting policies to promote animal husbandry. Policies to expand 
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and promote animal production should consider public health threats and ensure appropriate 
disease prevention and control initiatives are implemented. Policy-makers, veterinarians, farmers, 
physicians and other stakeholders in animal production should be aware of the re-emergence of 
brucellosis and the occupational risk for small ruminant farmers and their families.  
Limitations for this analysis include a potential bias in using data collected for the 
surveillance system. Farms participating in the surveillance system were actively registered with 
the DLD and voluntarily agreed to be tested for brucellosis. These farms may not be 
representative of farms at the national level. An additional limitation of this data is the lack of 
information on farm level characteristics including the exact location of the farm within the 
province and information linking farms to herd.   
Conclusion 
This study characterized the seroprevalence of brucellosis in small ruminants in Thailand 
using data from the Thai National Surveillance System. Review of surveillance data is an 
important measure to understand the impact of brucellosis control efforts and to identify areas 
where targeted response is needed. Overall this study identified that brucellosis seroprevalence in 
small ruminants may be decreasing throughout Thailand. However, there is variability in the 
distribution of the disease with some regions experiencing significantly higher rates of disease 
than others. With the increasing goat population, potential human health consequences should be 
taken into consideration when adapting animal husbandry policy. Policies to control brucellosis 
should be continued and strengthened to further reduce brucellosis. The DLD should ensure that 
farmers have access to education and training opportunities on the prevention and control of 
brucellosis. Next steps for improving understanding of brucellosis in Thailand would be to 
investigate and document goat movement between countries and provinces. Findings from this 
study can be used to strengthen control efforts to improve the management of the disease in 
Thailand.  
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Chapter 4 
Governance and policy to address antimicrobial resistance and 
antimicrobial use in animals and agriculture in Southeast Asian 
countries  
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SUMMARY 
Policy plays a critical role in controlling and preventing the growth of antimicrobial 
resistance (AMR). A range of policy recommendations have recently been proposed to combat 
AMR at the national level (WHO, 2016; Dar et al., 2016; O’Neill, 2016). Understanding what 
national policies already exist is important to ensure informed policy recommendations are made. 
This analysis provides a deeper understanding of Southeast Asian countries’ AMR and 
antimicrobial use (AMU) policy in food and agriculture. Policies and proposed strategies from 
Lao PDR, Myanmar, Viet Nam, Cambodia and Indonesia were compared. Key documents 
reviewed ranged from drafted and officially approved National Action Plans to food and animal 
production legislation, including animal husbandry regulation and pharmaceutical law. 
Regulations across four policy domains were examined: (1) governance; (2) infection prevention 
and control; (3) awareness and education; and (4) evidence. In total, the analysis reviewed over 
230 policy documents directly or indirectly related to AMR and AMU.  
The analysis revealed countries have existing policy that can be used to address AMR at 
the national level. Most countries have enacted pharmaceutical and animal husbandry laws to 
regulate the use of antimicrobials in animals and agriculture. Most countries require prescriptions 
for use of antimicrobials in animals, and most encourage responsible distribution of 
antimicrobials through advertising and labeling standards. Several countries prohibit counterfeit 
drugs and overselling antimicrobials. Many countries are also starting to implement bans of 
specific antibiotics for use in animals and have established policy goals to eliminate or restrict the 
nontherapeutic use of antimicrobials. With the development of National Action Plans to address 
AMR, many countries have the foundation to develop AMR/AMU awareness initiatives, to 
provide support for surveillance and monitoring systems, and improve infection prevention and 
control systems. Despite a plethora of existing policy, several limitations exist. Existing policies 
suffer from weak or nonexistent standards for limiting or reducing the use of critically important 
  
50 
and nontherapeutic use of antimicrobials. Most countries do not have legislation that specifically 
bans the use of antimicrobials for use as growth promoters or for disease prevention. Although 
data regarding enforcement is sparse, the effectiveness of existing policy is likely weakened as a 
result of insufficient enforcement capacity, infrastructure, and funding. 
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INTRODUCTION 
Antimicrobial resistance (AMR) is one of the most significant global health threats 
(World Health Organization, 2015; Food and Agriculture Organization, 2016). AMR and 
antimicrobial use (AMU) present complex policy challenges requiring effective governance and 
coordination across sectors (Dar et al., 2016; Årdal et al., 2015; OECD, 2016). The 2016 O’Neill 
Review argues that if significant policy change does not occur, AMR related human deaths will 
increase to ten million worldwide by 2050 (O’Neill, 2016).  Increased use of antimicrobials in 
animal husbandry pose a significant concern for potential spread of AMR to the environment and 
to humans (Hershberger et al., 2004; Speksnijder et al., 2014). There is increasing consensus that 
unnecessary use of antibiotics in animals and agriculture pose a significant concern for animal 
and human health (O’Neill, 2016). Antimicrobial resistant microbes carried by infected animals 
can transfer to humans through consumption of contaminated food, direct contact with animals, 
or through the environment (OECD, 2015; Landers et al., 2012; Ventola, 2015). Use of 
antimicrobials in the livestock production industry for therapeutic and nontherapeutic purposes, 
such as growth promotion and prophylaxis, is widespread across Southeast Asia (Nhung et al., 
2015).  
Significant drivers of AMR in this region include limited regulation and weak 
governance, including a lack of enforcement and compliance with policy (FAO, 2016; Gelband, 
et al., 2014; Landers et al., 2012). Governments often have limited capacity to fully implement 
policies due to a lack of technical capacity and inadequate financial resources (Gelband, et al., 
2014; Landers et al., 2012). This is particularly problematic, as efforts to control the spread of 
AMR are primarily governance issues, and governments are the primary actor responsible for 
how countries respond to this threat (O’Neill, 2016). 
AMR is becoming a top priority on political and policy agendas with a range of 
recommendations recently proposed (WHO, 2016; Dar et al., 2016). In 2015, the World Health 
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Assembly, in coordination with the World Organization for Animal Health (OIE), and the Food 
and Agriculture Organization (FAO), adopted a Global Action Plan (GAP) on AMR. The GAP 
outlines specific recommendations for countries to decrease and prevent the spread of AMR. A 
key recommendation of the GAP is the development of country specific National Action Plans 
(NAPs). The GAP expects all WHO Member States to develop their own NAP in line with the 
GAP by May 2017 (WHO, 2015). 
To more effectively strengthen national AMR policy in Southeast Asia, understanding 
existing regulatory activities is essential. Using a set of policy benchmarks identified from key 
global AMR documents, this report compares and contrasts policy from Laos, Cambodia, Viet 
Nam, Myanmar, and Indonesia. Countries selected for this analysis have comparable animal 
production systems and regulatory frameworks and are at similar stages in addressing AMR in 
animals and agriculture (Nhung et al., 2015). Overall this analysis contributes to a more 
comprehensive understanding of whether governments have established policy that can be used to 
protect public and animal health from AMR. 
RESEARCH DESIGN  
This analysis was guided by a set benchmarks identified in key AMR guidance 
documents. Guidance documents reviewed included the World Health Organization (WHO) GAP 
on Antimicrobial Resistance, the FAO Action Plan on Antimicrobial Resistance, the Global 
Health Security Agenda Antimicrobial Resistance Action Package, the 2016 World Bank Report 
“Drug-Resistant Infections: A Threat to Our Economic Future”, the 2016 O’Neill Review on 
AMR, the WHO Manual for Developing National Action Plans and others. Four policy domains 
were identified in these guidance documents: (1) governance including regulation of 
antimicrobials; (2) infection prevention and control; (3) awareness and education; and (4) 
evidence. Where necessary, policy subdomains further divide the analysis process. The guidance 
documents were also used to derive sub-domains and criteria to assess, compare, and contrast 
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policies for each policy domain. These criteria are listed under each policy domain in Tables 4-1, 
4-3 and 4-5. 
Due to the nature and complexity of AMR, it is rarely embodied in a single, 
comprehensive, stand-alone policy. As a result, this analysis interprets the concept of AMR and 
AMU policy broadly in analyzing laws, regulations, and other soft-policy. The Food and 
Agriculture Organization (FAO) defines policy as the stated objectives that a government seeks to 
achieve and sustain a decision or a set of decisions made by individuals, organizations, or 
governments that are oriented toward addressing a topic or issue such as AMR (FAO, 2016).  
Key types of policy reviewed include, drafted and approved NAPs; food and animal 
production policy including animal husbandry regulation; and pharmaceutical legislation. This 
analysis relied primarily on official government publications, open access legal databases, and 
collections of legal documents published by international organizations including FAO’s legal 
and policy database (FAOLEX, 2017). In some cases, national AMR policy experts and ministry 
staff assisted in identifying and providing access to additional policy documents. In total, over 
230 policy documents were reviewed. For a list of key documents reviewed for each country see 
Appendix 1.   
This analysis uses the OIE definition of antimicrobial agents: “a naturally occurring, 
semi-synthetic or synthetic substance that at in vivo concentrations exhibits antimicrobial activity 
(kills or inhibits the growth of micro-organisms). Anthelmintics and substances classed as 
disinfectants or antiseptics are excluded from this definition” (OIE, Terrestrial Animal Health 
Code, 2010). The inclusion of policies on the development of new antimicrobial drugs is not 
included because this is not a key recommendation nor is it feasible for most low and middle 
income countries (World Bank, 2016). 
Limitations of this analysis include lack of information on how or if the policy has been 
implemented, enforced or its effectiveness. Second, this paper focuses on animals and agriculture 
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and does not include information on policy related to use and AMR in humans. Third, many 
policies were translated from the official language to English. Translation of complicated legal 
language can result in misinterpretation and missing information. Significant effort was taken to 
ensure the author’s understanding of the translation was accurate and consistent with the original 
text. 
POLICY REVIEW 
Governance  
Governance is at the core of national efforts to reduce or eliminate AMR (FAO, 2016; 
World Bank, 2016). Recommendations from AMR guidance documents for improving AMR 
governance include developing a NAP, establishing mechanisms to address AMR, implementing 
multi-sectoral coordination, and strengthening policy. Examples of mechanisms to address AMR 
include working groups, delegating specific missions to ministries or other national-level bodies 
to manage AMR and antibiotic issues and others. Table 4-1 lists three subdomains and details the 
specific criteria used to assess the policies analyzed under the Governance policy domain. 
Table 4-1. Governance Practices and Mechanism(s) to Address AMR and AMU in Food and 
Agriculture  
Policy Subdomain Criteria 
National Action Plans 
 
• Has the government approved an AMR National Action Plan?   
o If yes, is this plan published with open access?  
o If yes, does the NAP align with the objectives described in the Global 
Action Plan? 
Mechanism to Address 
AMR 
• Have mechanisms been established to coordinate multi-disciplinary efforts 
to address AMR at the national level across sectors and agencies?  
o  If yes, how formularized are the relationships between sectors in 
relation to tactics to address AMR? (i.e. mutual aid agreements, 
MOU’s, informal agreements, inter-ministerial declarations, etc.) 
• Is there a ministry office or department with an explicit mission to address 
AMR and AMU in animals and agriculture? 
Regulation of 
Antimicrobials 
• Does policy define procedures to control the quality and standards of 
veterinary medicines?  
o If yes, do these procedures prohibit the use and distribution of 
counterfeit or substandard antibiotics? 
• Is a definition given for veterinary medicines, particularly antimicrobials 
for use in animals and agriculture?  
• What measures has the government taken to eliminate, reduce or restrict 
the nontherapeutic use of antimicrobials in animals and agriculture?  
• Does policy prohibit or restrict the use of critically important 
antimicrobials in animals?  
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• Does policy address the use of antimicrobials in animal feed?  
o Does policy establish standards to ensure the safety and quality of 
antimicrobials in animal feed? (i.e. testing requirements?)   
o Does policy prohibit or limit antimicrobials in animal feed?  
• Are there standards for advertising antimicrobials for use in animals?  
• Are there labeling requirements for antimicrobials for use in animals?   
• Is a prescription required for antimicrobial use in animals? 
o If yes, does policy describe who can administer prescription(s)?  
• Does policy regulate:  
o Who can administer antimicrobials to animals? 
o Who can sell antimicrobials for use in animals?  
o Where antimicrobials can be sold for use in animals? (business 
retailers, pharmacies, etc.) 
• Does policy address the environmental dimension of AMR?  
• Do national policies to address AMR include stakeholders from the 
environmental sector? (i.e. ministry of environment) 
 
National Action Plans  
Viet Nam was the first of the countries reviewed to officially endorse a NAP. In 2013, the 
Vietnamese Ministry of Health released the National Action Plan on Combatting Drug Resistance 
(2013 – 2020). Cambodia has three key guidance documents promoting action to address AMR. 
In 2014, Cambodia released its National Action Plan to Reduce the Threat of AMR Related to 
Agriculture, Fisheries, Food and Livestock Production (2016 – 2020). Although this NAP is 
endorsed at the ministerial level it is not technically binding law. The second national document 
for AMR in Cambodia is the National Strategy to Combat Antimicrobial Resistance (2015 – 
2017). Additionally, the One Health Roadmap on AMR (2017 – 2021) has been drafted to guide 
multi-sectoral action. In Indonesia, the NAP is under development with the goal of submission to 
the World Health Assembly in May 2017. Laos is developing its NAP and held its first 
stakeholder meeting to begin the drafting process in November 2016. Laos’s NAP is a joint effort 
by the Ministry of Health and the Ministry of Agriculture and Forestry. As of May 2017, an AMR 
NAP has not been officially endorsed by a ministry or the government of Myanmar. However, 
ministerial staff indicate that this plan is being drafted.  
Existing NAPs are strongly influenced by the GAP and broadly address the five 
objectives described in this guidance document. However, the language used to describe these 
objectives are somewhat different for each country. For example, Viet Nam’s NAP includes the 
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following objectives: (1) to raise awareness of community and health workers on drug resistance; 
(2) to strengthen and improve national surveillance systems on the use of antibiotics and drug 
resistance; (3) to ensure adequate supply of quality medicines to meet the needs of people; (4) to 
promote proper safe use of drugs; (5) to promote infection control; (6) to promote proper safe 
antibiotic use in livestock, poultry, aquaculture and cultivation. In Cambodia, the objectives 
included in the national strategy were informed by the GAP and modified to fit the national 
context. Cambodia’s NAP focuses on the following objectives (1) strengthening laboratory 
capacity and AMR surveillance; (2) ensuring uninterrupted access of essential medicines of 
assured quality; (3) regulating and promoting rational use of medicines; (4) enhancing infection 
prevention and control; and (5) fostering innovation and research and development of new tools. 
It is interesting to note that regionally there is coordination between countries to address 
AMR. One example of this coordination includes the development of the Association of 
Southeast Asian Nations (ASEAN) Regional Action Plan on AMR finalized in July 2016. 
Additionally, through the tripartite collaboration, WHO, OIE and FAO have held regional 
workshops to assist countries with preparing and refining their NAPs (WHO, 2017).  
Governance Coordination to Address AMR 
Multi-sectoral Coordination   
Coordination across sectors is essential for effective national response and control of 
AMR (Årdal et al., 2015; Nweneka et al., 2009). Policy support for inter-sectoral coordination 
and the formality of this coordination differs across the countries. All countries reviewed have 
established a national multi-sectoral steering committee or working group for addressing AMR or 
are in the process of finalizing these committees. Most committees were established with the 
mandate to create and implement the NAP. For example, Cambodia’s AMR Working Group was 
established in 2012 and serves as the main coordinating entity for AMR activities at the national 
level. This working group is coordinated by the Ministry of Health and is mandated by the 
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National Policy to Combat AMR to include representatives from different sectors. Viet Nam 
provides examples of policy support for multi-sectoral collaboration with the recent 
implementation of several decrees and circulars to support coordination between sectors 
(Strengthening Capacity for the Implementation of One Health in Viet Nam, 2015; Inter-
Ministerial Circular No. 16/2013/TTLT-BYT-BNN&PTNT, 2013). In 2014, Viet Nam’s Ministry 
of Health, Ministry of Agriculture and Rural Development, Ministry of Trade and Industry and 
Ministry of Natural Resources and Environment and other development partners signed an aide-
memorandum to coordinate and jointly implement the NAP across sectors.  
Delegation of Authority to Address AMR 
NAPs are typically the only policy document that explicitly delegate authority to a 
ministry or department to address AMR and AMU in agriculture and animals. This is 
problematic, as NAPs are typically not binding law. In Cambodia’s National Action Plan to 
Reduce the Threat of AMR, the Ministry of Agriculture, Forestry, and Fisheries (MAFF) is 
directed to implement activities that address AMR and AMU in the livestock and agriculture 
sector. In Viet Nam, the Ministry of Agriculture and Rural Development has been assigned to 
address specific aspects of AMR in animals and agriculture including developing regulations on 
the use of antimicrobials in animals.  In Laos, Myanmar and Indonesia, no policy has been 
identified that mandates or designates a specific office to address AMR. However, legislation in 
these countries mandates that ministries address disease prevention in animals. A good example 
of this delegation comes from Laos. Laotian law states that the Ministry of Agriculture and 
Forestry has the authority to issue regulations for veterinary services, animal health, and 
prevention and control of epidemic diseases. In addition, the law designates the Livestock and 
Veterinary Management Authority to manage a list of animal diseases, and regulate activities to 
prevent and control these diseases. 
Regulation of Antimicrobials 
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Review of policies related to the regulation of antimicrobials described eight topics: (1) 
quality standards; (2) nontherapeutic use; (3) animal feed; (4) rational use; (5) use of critically 
important antimicrobials; (6) prescription requirements; (7) authorized retailers; and (8) 
advertising and labeling standards.  
Quality standards  
Quality standards help to eliminate or reduce use of substandard antimicrobials. There is 
no standard definition of poor quality medicines however, WHO uses the SSFFC acronym to 
describe “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” (WHO, 
2012).  Research is currently limited linking low quality drugs directly to AMR. However, 
researchers have demonstrated that certain sub-standard drugs can promote AMR (Leslie et a l., 
2009). For instance, poorly manufactured drugs may dissolve incorrectly in the gastro-intestinal 
tract and influence the amount and rate at which the active ingredient is released into the 
bloodstream. This is known to promote the development or replication of resistant pathogens 
(Lesile et al., 2009).  
All countries reviewed have policies and standards on the production, importation and 
exportation of veterinary medicines. Most policies require veterinary drugs to be registered with a 
designated authority (Viet Nam 2015 Law on Animal Health; Cambodia Law on Animal Health 
and Production and Joint Prakas No. 363; Myanmar Animal Health and Development Law, Lao 
Law on Drugs and Medical Products). All countries have standards that must be followed for 
veterinary drugs to be registered. Additionally, all countries have procedures to control the 
quality of veterinary medicines. These procedures are typically set by ministries of agriculture. 
Quality standards regarding the distribution of veterinary pharmaceuticals are important for 
reducing manufacturing and use of counterfeit and substandard drugs. Countries such as Laos, 
often describe in policy that their safety requirements are based on international standards and 
recommendations. Departments or divisions within a ministry are usually directed to monitor and 
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inspect veterinary medicines. For example, Cambodian law designates the MAFF to investigate, 
regulate, inspect, and monitor all transactions related to veterinary medicines. In Indonesia, 
veterinary drug inspectors at the district and provincial livestock service offices carry out control 
and inspections related to veterinary drugs. 
A few countries have stand-alone regulations ensuring quality manufacturing of 
veterinary drugs. In Indonesia, guidelines for good manufacturing practices (GMP) for veterinary 
medicines were introduced in 1999 (Decree of MOA no. 466, 1999). Viet Nam and Laos both 
prohibit the use and distribution of fake or counterfeit veterinary pharmaceuticals. Cambodia does 
not explicitly prohibit fake or counterfeit products, but does ban the use of prohibited substances 
that are harmful to animals and humans. All countries reviewed provide a definition of veterinary 
pharmaceuticals in legislation. In Myanmar, the definition includes both veterinary and human 
pharmaceuticals. However, most laws governing the use of pharmaceuticals in animals and 
agriculture do not explicitly mention or define antimicrobials. 
Nontherapeutic use of antimicrobials in animals   
Countries have limited policy regulating the nontherapeutic use of antimicrobials in 
animals. Most countries do not have legislation that specifically bans the use of antimicrobials for 
growth promotion or disease prevention. Viet Nam and Cambodia have proposed bans on specific 
nontherapeutic use of antimicrobials in national strategies to address AMR (Viet Nam’s 
Integrated One Health Action Strategic Plan; Cambodia National Strategy to Combat 
Antimicrobial Resistance). Viet Nam banned and restricted certain antibiotics for use in animals 
and agriculture. However, in Viet Nam no specific guidelines are given for the nontherapeutic use 
of antibiotics in animals. Viet Nam plans to implement, by 2020, a ban on the use of 
antimicrobial agents for growth promotion in livestock. Further, Viet Nam plans to ban 
prophylactic treatment of young chickens with colistin (Viet Nam’s Integrated One Health Action 
Strategic Plan). Cambodia’s National Strategy to Combat AMR, describes a ban on the 
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nontherapeutic use of antibiotics in food animals and restrictions are proposed to limit the use in 
animals of critically important antimicrobials for human health. These proposals are expected to 
be implemented in 2017 by Cambodia’s MAFF. Indonesia has banned the use of certain drugs 
including chloramphenicol and hormone growth promoters in all food producing animals (Decree 
no. 806, Veterinary Drugs Classifications from the Minister of Agriculture, 1994). No policy 
regarding nontherapeutic use of antimicrobials were identified in Laos or Myanmar.  
Antimicrobials in animal feed  
Policies to ensure quality standards for the distribution and use of animal feed exist in all 
countries. However, such policies are often limited in scope. All countries have a definition on 
what constitutes animal feed and have set requirements for maintaining quality standards. Most 
countries also require animal feed to be tested to ensure safety. For instance, a law in Myanmar 
defines animal feed and stipulates that animal feed must be inspected. In addition, animal feed 
retailers must obtain certificates requiring animal feed be tested for harmful pathogens and toxins. 
In Cambodia, there is no provision specifically addressing the use or sale of medicated feed. 
Under Cambodian law, however, it is illegal to use animal feed that contains prohibited 
substances including harmful or fraudulent substances, abnormal animal growth substances, or 
prohibited genetically modified organisms harmful to humans and animals (Law on Animal 
Health and Production). Similar policy exists in Laos, where the law requires animal feed 
producers to comply with technical standards relating to production premises, feed production 
systems, and quality control of feed. 
Some countries have policies that ban the use of certain antibiotics in animal feed. For 
instance, Viet Nam has banned eighteen different kinds of antibiotics for use in animal feed. 
However, certain antibiotics may legally be added to feed for food animals, for both prophylaxis 
and growth promotion and some of these antibiotics are critically important for human medicine 
(Circular 28/2014 / TT-BNN; Clause 1, Article 3 of Decree 08/2010/ND-CP). There are some 
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inconsistencies in Viet Nam on the types of antibiotics that can be used in animal feed, and what 
types can be directly administered to animals. Twelve types of antibiotics have been banned for 
direct administration to animals, including bacitracin zinc in Viet Nam. However, bacitracin zinc 
can be added to animal feed for use in chickens and pigs (Circular No. 03/2012 / TT-BNN; 
Decree 08/2010/ND-CP). Indonesian law prohibits mixing chloramphenicol, tetracycline, and any 
hormone growth promoter with animal food. Additionally, Indonesian law explicitly prohibits 
mixing antibiotic additives in animal food (Law No. 18 of 2009 Concerning Husbandry and 
Animal Health). For more information on specific legislation to regulate animal feed and the 
implementing agency, see Table 4-2. 
Table 4-2. Regulation of antimicrobial use in animal feed and implementing agency by 
country   
Country Regulation of antimicrobial use in animal feed  Implementing Agency  
Indonesia • Law No. 65  
• CAC/RCP 38-1993 
• Law No. 18 of 2009 Concerning Husbandry and Animal 
Health 
Ministry of Agriculture 
Cambodia • Law on Animal Health and Production, 2016;  
• Prakas on Procedures for Permits Issuance and Technical 
Standards for Importing, Exporting, Mixing, Repackaging, 
Stocking, Distributing, Doing Wholesales and Retails of All 
Kinds of Veterinary Medicines and Veterinary Biologicals;  
• Prakas on Procedures for the Management of Commercial 
Veterinary Medicines and Veterinary Biologicals and 
Mixing of Veterinary Medicines.  
Ministry of Agriculture, 
Forestry and Fisheries  
Viet Nam • Circular 28/2014 / TT-BNN 
• Decree 08/2010/ND-CP 
• Circular No. 03/2012 / TT-BNN 
• Decree 08/2010/ND-CP 
• Decree on Animal Feed 
• Terrestrial Animal Health Code 
• 2015 Law on Animal Health 
Department of Livestock; 
Ministry of Agriculture and 
Rural Development  
Laos • Law on Livestock Production and Veterinary Matters 
• Technical Norms on Livestock and Livestock Production 
Management  
Agriculture and Forestry 
Sector; 
Ministry of Agriculture and 
Forestry  
Myanmar • Animal Health and Development Law Livestock Breeding and 
Veterinary Department, 
Ministry of Agriculture and 
Irrigation  
 
Rational use of antimicrobials   
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This review identified policies that encourage rational use, create stewardship programs, 
or discouraged the excessive sale and misuse of antibiotics. Policy in most countries does not 
explicitly describe or mandate promotion of the rational use of antimicrobials in animals. In Viet 
Nam and Laos, law specifically states that drugs must be used in accordance with the 
manufacturer’s instructions. Laws also require medicines be taken in compliance with the 
objectives of the prescription (Law on Drugs and Medical Products; Animal Health Law; Circular 
No. 50/2009 / TT-BNN and Circular 50/2010 / TTBNN). The law specifically states that 
pharmacists and businesses are prohibited from promoting misuse or overselling medicines (Law 
on Drugs & Medical Products). In Indonesia, codes of practice were created to promote the 
prudent use of veterinary drugs. These codes are harmonized with the Code of Practice for 
Control of the Use of Veterinary Drugs (CAC/RCP 38-1993). The Code includes guidelines on 
the use of veterinary drugs in animal feed, and the use of veterinary drugs by authorized 
companies, institutions or personnel. In Viet Nam and Cambodia, activities to promote 
antimicrobial stewardship in animal food production are also described in each country’s NAP.  
Use of critically important antimicrobials  
Critically important antimicrobials in human health are drugs that are critical for treating 
diseases in humans (WHO, 2011). WHO states that “improved management of the use of 
antimicrobials in food animals, particularly reducing those critically important for human 
medicine, is an important step towards preserving the benefits of antimicrobials for people” 
(WHO, 2017).  Countries have few policies designed to prohibit or restrict the use of critically 
important antimicrobials in animals and agriculture. Viet Nam, Cambodia, and Indonesia have 
legislation that prohibits use of veterinary drugs in animals if that drug demonstrates harm in 
humans. However, this legislation lacks a definition on what is considered harmful to human 
health, despite frequent use of the term. More importantly, none of the laws use the term 
“critically important antimicrobials.” Vietnamese law states that “upon detection of veterinary 
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drugs harmful to humans, animals and the environment” the drug in question can no longer be 
used, and the harmful effects must be “immediately report[ed] to the commune-level People's 
Committees or the local veterinary specialized agency” (2015 Animal Health Law).  
Viet Nam also has legislation that limits the use of certain antibiotics. However, not all 
antibiotics classified as critically important for use in humans are banned for use in animals in 
Viet Nam (Circular No. 15/2009 / TT-BNN; Circular No. 29/2009 / TT-BNN; Circular No. 
20/2010 / TT-BNN). Cambodian law offers a similar prohibition on drugs that harm humans. The 
law states that if any component for compounding veterinary medicine is harmful to human 
health, the certificate of registration for such medicine can be revoked. However, the law does not 
define what is considered harmful to humans and does not mention antimicrobial resistance. 
Indonesia has legislation that prohibits the use of animal medicines in livestock that are meant for 
consumption by humans (Law No. 18 of 2009 Concerning Husbandry and Animal Health). Any 
person that administers medicine to an animal intended for human consumption will be subject to 
imprisonment for at least 3 months and is required to pay a fine (Article 90, 2009 Law 
Concerning Husbandry and Animal Health). Myanmar and Laos currently have no legislation or 
regulation restricting the use of critically important antimicrobials in animals and agriculture.  
Prescription requirements for antimicrobial use 
Policies on prescription requirements for antimicrobial use in animals are quite varied 
between countries. In Viet Nam, Myanmar, Indonesia and Laos, policy describes that 
pharmaceutical drugs for use in animals must be administered with a prescription. In Myanmar 
and Laos, legislation on prescription requirements for pharmaceuticals encompass both animal 
and human drugs. For instance, in Myanmar’s National Drug Law states that prescription drugs 
must not be sold to anyone except by written prescription from a registered physician, dental 
surgeon or veterinary surgeon. In Indonesia and Viet Nam, veterinary pharmaceuticals may only 
be obtained with a veterinarian’s prescription. Viet Nam and Indonesia stipulate specific 
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conditions that veterinary practitioners must meet to practice veterinary medicine. In Cambodia, 
there is no law specifically stating that a prescription is required for antibiotic use in animals. 
Cambodian law directs the MAFF to “regulate trade, production, mixture, prescription and the 
usage of veterinary medicines, veterinary biologicals, and veterinary materials” (Cambodia Law 
on Animal Health and Production). Countries provide very limited regulation about who is legally 
allowed to administer drugs to animals. Only Indonesia regulates who may legally administer 
drugs to animals.  Indonesian law requires veterinary medicines be used only under the 
supervision of a veterinarian or member of the Animal Health Force (Law No. 18 of 2009 
Concerning Husbandry and Animal Health). No guidelines were identified in any of the countries 
reviewed that describe the relationship between farmers and veterinarians and prescription 
requirements  
Authorized retailers of antimicrobials 
Most countries have very specific policy delineating requirements for veterinarians, 
pharmacies or businesses seeking to sell animal pharmaceuticals. Most policy mandates that 
pharmacies or other medical businesses must first register with a designated agency prior to 
making any sales. The registration process is varied, but typically consists of proof of national 
identity and credentials. Limited regulation and guidance is given on whether a licensed 
pharmacist or veterinarian is required for businesses to sell drugs.  Some countries, such as Viet 
Nam, have specific training requirements for pharmacists or drug-retailers before they may sell 
antimicrobials for use in animals. Similarly, Cambodian regulation requires any institution selling 
veterinary medicines to have a license. In Cambodia, only veterinarians can apply for a license 
from the Ministry of Agriculture, Forestry, and Fisheries to sell veterinary medicines (Joint 
Prakas No. 363). In addition, Cambodia prohibits veterinarians from directly selling animal 
pharmaceuticals—including antibiotics—to farmers, unless they have a specific permit issued by 
MAFF. 
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Myanmar has limited policy on who can sell veterinary pharmaceuticals. Myanmar’s 
National Drug Law states that a business can sell pharmaceuticals as long they apply for and are 
granted a drug retailer’s license. In Indonesia, any business manufacturing, preparing, or 
circulating animal medicine must have a business license (Law No. 18 of 2009, Concerning 
Husbandry and Animal Health). Other Indonesian laws stipulate that drug retailers must have a 
part-time veterinarian, pharmacist, or a full-time assistant pharmacist, as the person-in-charge 
(Law on Hard Drugs, 1949). In Laos, law outlines provisions on who can sell antimicrobials and 
stipulates that the sale of drugs and medical products be conducted by authorized retail 
pharmacies only. Policies regulating where veterinary pharmaceuticals can be sold is weak. In 
Viet Nam, requirements for where veterinary pharmaceuticals can be sold are limited to quality 
standards for the physical premise. Similar requirements exist in Laos, Myanmar and Cambodia. 
In Indonesia, antibiotics for use in animals can be sold in ‘depot distributors of veterinary drugs 
or pet shops’ (Minister of Agriculture Decree No. 806/Kpts/TN.260/12/94). Requirements are 
described for depot distributors including licensing requirements standards for cleanliness.   
Advertising and labeling  
Regulation on advertising veterinary pharmaceuticals is similar among countries. In Viet 
Nam, regulation prohibits advertising prescription drugs, including antibiotics, to the public in 
any form (Law on Pharmacy, 2005). Cambodia, Laos, Myanmar and Indonesia require drugs be 
registered and comply with specific requirements before being advertised. In Cambodia, 
advertisers of veterinary pharmaceuticals must comply with mandates from the Animal Health 
and Production Unit under the MAFF (Law on Animal Health and Production). Myanmar’s 
National Drug Law, allows registered drugs to be advertised that comply with very specific 
requirements. Further, drugs that require a prescription can only be advertised to doctors, dental 
surgeons, veterinary surgeons, nurses, pharmacists, and paramedics. Indonesia requires that all 
advertising materials be submitted to the Indonesian National Agency of Drug and Food Control 
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(NADFC) for approval prior to advertising. Laotian law prohibits unapproved drugs being 
advertised and it is illegal for advertisements to make any misleading claims for approved drugs 
(Drugs and Medical Product Law).  
All countries have labeling requirements of veterinary pharmaceuticals. However, label 
requirements differ greatly. For most countries, requirements are described in national 
pharmaceutical and drug laws. All countries have minimum standards that the label be written in 
the native language, state the active ingredient, comply with registration requirements, and 
provide instructions for use (Cambodia 2015 Law on Animal Health; Myanmar National Drug 
Law; Viet Nam 2015 Law on Animal Health; Laos Drugs and Medical Product Law; Indonesia 
Government Regulation No. 78). In Myanmar, Viet Nam and Indonesia, drugs used for veterinary 
purposes must state “for animal use only” on the label. Viet Nam has legislation that requires that 
“the withdrawal/withholding time for each animal species to be treated” be clearly stated on the 
label of antibiotics used in animals (Circular No. 03/2009). Withdrawal time is the time that the 
antibiotic should stop being used to clear the animal’s system before the animal is slaughtered, to 
ensure products from that animal are free from unsafe antibiotic residues. Laotian law requires 
that drugs carry a seal of approval from the Laos Food and Drug Department to help distinguish 
unregistered drugs.  
The environment  
Increased use of antimicrobials in animal husbandry is a significant concern for potential 
spread of AMR and antimicrobial residues to the environment and to humans (Hershberger et al., 
2004; Speksnijder et al., 2014). Resistant organisms and antimicrobial residues can spread into 
the environment in several ways through various animal husbandry practices, and farm and 
pharmaceutical run-off (Hershberger et al., 2004). Consideration of the relationship between the 
environment and AMR is very limited in national policies. Viet Nam has made important steps in 
addressing environment concerns as it relates to AMR. Viet Nam includes the Health 
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Environmental Management as a commissioner in the Steering Committee for implementing the 
NAP. Guidelines for controlling the spread of drug-resistant microorganisms in the environment 
were jointly drafted by Viet Nam’s Ministry of Natural Resources and Environment, Ministry of 
Health, and the Ministry of Agriculture. Viet Nam’s Environmental Protection Law requires the 
Minister of Natural Resources and the Environment to unify each state’s environmental 
protection. Under this law, the Ministry of Natural Resources and Environment issued a list of 
hazardous wastes and standards for hazardous waste management (Decree 38/2015/ND-CP, 
Circular 36/2015/TT-BTNMT). This list includes management of hazardous waste related to 
antibiotics and antibiotic resistance (Circular 36/2015/TT-BTNMT). Cambodia has enacted 
several policies to help prevent the discharge of harmful substances, including antimicrobials, 
into the environment (Law on Fisheries; Law on Pesticides and Fertilizers). The Prakas on 
Medical Waste Management (2009) prohibits antibiotics from being discharged into the public 
sewer system. The Cambodian Law on Pesticides and Fertilizers prohibits disposal of pesticides 
on land and into water sources that could be harmful to the environment.  
Infection Prevention and Control  
 
Policy specific to biosecurity (e.g. prevention and control of containments) can minimise 
the spread of pathogens, including those that are resistant. This decreases the likelihood of 
infection, and thereby reduces the overall need for antimicrobials (FAO, 2017; WHO, 2017; 
O’Neill, 2016). Effective infection prevention and control is critical for reducing the volume and 
number of antimicrobials used in animal husbandry and therefore limiting the opportunity for 
drug resistance strains from developing (O’Neill, 2016). Husbandry factors that contribute to 
AMR include poor biosecurity measures such as inadequate disinfection and animal housing 
cleaning. Additional practices that contribute to AMR include practices that promote stress on 
animals (i.e. transport of animals, stocking density, etc.). Best management practices, and 
industry standards can be used to set standards that ensure safe and sustainable husbandry 
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practices. When implemented, these standards can minimize the spread of AMR in the 
environment. Table 4-3. describes the criteria used to assess policies related to infection 
prevention and control specific to AMR in animals and agriculture. 
Table 4-3. Policies related to infection prevention and control and AMR and AMU in animals 
and agriculture  
Policy 
Subdomain 
Criteria 
Infection 
Prevention 
and Control 
•  Has the government established infection prevention guidelines for animals and 
agriculture? 
• Does policy require infection prevention training specific to AMR for animal health 
workers, animal food producers (i.e. farmers), veterinarians, or others?  
 
Several NAPs describe infection prevention and control efforts to address AMR in 
animals and agriculture. For instance, Viet Nam and Cambodia’s NAPs describe targets for 
improving infection prevention and control efforts, including enhancing farm biosecurity 
measures and promoting good animal husbandry practices. Activities described in Cambodia’s 
NAP, include increasing vaccination coverage, promoting biosecurity measures at the farm level, 
strengthening the control of animal movement and enforcing existing legislation on disease 
management. The Cambodian NAP describes activities for AMU and AMR training for village 
animal health workers. Viet Nam’s NAP calls for conducting trainings for health workers on 
AMR treatment guidelines. In its NAP, Viet Nam also aspires to “gradually improve the system 
of legal documents and instructions on technical expertise in infectious disease control, infection 
control, surveillance of drug resistance and enhancing rational drug use” (Viet Nam, NAP on 
Combatting Drug Resistance, 2013).   
Several countries have policy guidelines on infection prevention and control but these are 
not specific to preventing AMR. For instance, Indonesian policy has guidelines for eradicating 
animal diseases and for improving infection prevention and control at the farm level (2009 Law 
on Husbandry and Animal Health). Under this law, efforts to control and prevent animal diseases 
include observation, identification, prevention, safeguarding, eradication, and/or medication. 
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However, this law does not provide specifications on antibiotic use nor does not it mention AMR. 
In Laos, livestock and veterinary guidelines exist for the prevention and management of animal 
diseases. These regulations do not however, mention AMR or AMU (Decree on the Control of 
the Movement of Animal and Animal Products and the Technical Norms on Livestock and 
Livestock Production). Laos’s Decree on the Prevention and Control of Animal Diseases provides 
the principles, regulations, processes, and methods for preventing and controlling animal 
diseases. The Technical Norms on Livestock and Livestock Production Management provide very 
specific disease management guidelines for animal diseases. Viet Nam’s veterinary law provides 
guidelines on disease prevention, quarantine of animals and animal products, slaughter control, 
and veterinary hygiene. In Cambodia, the 2016 Law on Animal Health and Production establishes 
specific standards for controlling and preventing the spread of animal diseases. This law describes 
guidelines on the management of animal health and production at a national level. Myanmar has 
similar regulations regarding disease inspection requirements, and certifications for disease free 
animals (Animal Health and Development Law). 
Awareness 
Awareness raising campaigns and education programs are key ways for countries to 
increase knowledge and understanding of AMR among stakeholders. The GAP recommends that 
countries take immediate steps to raise AMR awareness and promote behavior change among 
stakeholders. Further, FAO recommends that countries customize advocacy campaigns to target 
different stakeholders and present key messages that fit national contexts (FAO Action Plan on 
AMR, 2016). Recommended awareness raising activities include campaigns that use mass media 
to target the general public, and initiatives to improve educational curriculum in both academic 
and non-academic settings.  
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Table 4-4. Policy to Support Awareness and Education on Antimicrobial Resistance  
Policy 
Subdomain 
Criteria 
Awareness 
• Has the government established policy to increase national awareness of AMR 
among the general public?   
o If yes, does this include participation in an annual world or regional AMR 
awareness campaign? 
• Has the government established policy that supports inclusion of AMR and related 
topics in:  
o  Undergraduate and graduate curricula such as veterinary medicine? 
o Continuing education programs focused on veterinary, livestock and 
agricultural training?   
 
Most National Action Plans (NAPs) promote AMR awareness raising activities. Viet 
Nam’s NAP attempts to increase AMR awareness through mass campaigns targeting the general 
population, human healthcare professionals, and students. Additionally, the NAP recommends 
developing AMR curriculum for tertiary institutes and universities, providing AMR training to 
increase the capacity of clinical microbiology laboratories, and drug resistance prevention 
training programs through collaborations between domestic and foreign institutions. Cambodia’s 
NAP focuses on improving AMR training and education in undergraduate and graduate 
curriculum, as well as activities that target the general public through a mass media campaign. 
Cambodia’s National Strategy to Combat AMR, endorses plans to conduct seminars on AMR for 
human, animal and other related health professions.  
Although official participation in global AMR events is increasing, this participation is 
not recommended in policy or a national strategy document. Cambodia and Indonesia participated 
in World Antibiotic Awareness Week (WAAW) in 2016. This event included mass media events 
and activities. Laos participated in its first WAAW in 2015 and again in 2016, where it held its 
first multi-stakeholder workshop on AMR. Four ministries from Viet Nam participated in 
WAAW in 2015 and 2016. In 2016 events at the WAAW included a mass media campaign in the 
capital city that gathered pledges for responsible antibiotic use. A lecture series, targeting 
students and professionals, was also held at different locations around the country (WHO, 2016).  
Evidence   
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Documenting resistance through surveillance, monitoring, and research provides essential 
information for improving national responses to AMR. Evidence is critical for improving 
knowledge, informing appropriate prevention practices, and promoting the rational use of 
antibiotics. Countries can improve the evidence base by establishing policy that supports 
surveillance and monitoring systems for AMR and AMU. Scholarship recommends gathering two 
types of data to improve AMR/AMU evidence bases: (1) monitoring the number of AMR 
infections (isolates from AMR infected animals); and (2) monitoring antimicrobial consumption 
at the farm level (O’Neill, 2016). 
Policy should facilitate AMR research, beyond routine surveillance and monitoring 
activities. Research is important for improving knowledge and establishing evidence based 
policies. Priority research topics on AMR and AMU have been identified by WHO and FAO. 
Research topics range from interspecies transfer of AMR through humans, to agriculture and the 
food production environment, to understanding AMU and its impact on the farm environment 
(FAO Action Plan on AMR, 2016; WHO, 2016).  
Table 4-5. Policy Support for Building the Antimicrobial Resistance and Use Evidence Base 
Policy 
Subdomain 
Criteria 
Evidence 
• Has the government established policy to support the development and 
implementation of a national surveillance and monitoring system for AMR and 
AMU?  
• Has the government established policy to support research on AMR outside of 
surveillance and monitoring activities? 
• Does national policy include support for building or maintaining national 
laboratory capacity to identify antimicrobial resistant bacteria?   
 
There are currently no nationwide AMR surveillance or monitoring systems for animals 
among the countries reviewed. National Action Plans (NAPs) in Viet Nam and Cambodia endorse 
plans for establishing a surveillance system and developing a database on AMR and AMU in 
humans and animals. While countries do not have any national level surveillance programs 
established yet, many have specific research groups or academic institutions that analyse drug 
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resistance trends. Surveillance and monitoring activities have occurred in some countries. In 
Indonesia, a preliminary study was conducted in 2012 to monitor antimicrobial resistance in 
sentinel bacterial isolated from poultry meat from one area in West Java. In 2012, the program 
was continued and expanded to all of Java Island and is ongoing. An initial pilot program to 
monitor AMR ran from 2012 to 2013. However, it is recognized as a national-level program to 
monitor antimicrobial resistance in indicator bacteria (E. coli and Salmonella spp.) (Nhung et al., 
2016).  
Laboratory and human capacity to identify resistant bacteria are very limited in most 
countries. Many countries recommend strengthening laboratory capacity to detect AMR in NAPs. 
Viet Nam and Cambodia propose similar activities to improve laboratory capacity, including 
building laboratories and reference laboratories, improving standard test procedures, and creating 
guidelines for clinical microbiology laboratories. Viet Nam developed an AMR reference 
laboratory for antimicrobial stewardship (One Health Strategic Plan, 2016). Viet Nam has also set 
the goal to build a network of thirty laboratories across the country for detection of AMR. In 
Myanmar, two central veterinary diagnostic laboratories and four regional veterinary diagnostic 
laboratories exist. Indonesia has eight laboratories that test for animal diseases. These laboratories 
also have the capacity to test for veterinary drug residues and microbial containments. Indonesia 
also has Veterinary Public Health Laboratories located in districts and provinces, which can 
conduct simple tests of livestock products.  
Limited AMR research has been conducted in the countries reviewed. Viet Nam 
describes activities to promote scientific research on AMR in their NAP. Viet Nam’s NAP 
describes several research priorities: monitoring the circulation of counterfeit drugs in the market, 
developing evaluation indicators, and establishing a system for collecting and processing 
information. Viet Nam’s Integrated One Health Strategic Plan creates strategies for research on 
environmental and food reservoirs of AMR organisms.  
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Each country has policies that direct agencies to conduct research on various topics 
related to animal diseases and animal husbandry. For instance, in Indonesia, the Government and 
regional Governments are obligated to conduct research on animal diseases and development of 
husbandry and animal health (The Husbandry and Animal Health Law No. 18 of 2009). Other 
countries have legislation that mandates agencies to establish surveillance systems for different 
animal diseases of concern. For instance, Laos’s Decree on the Prevention and Control of Animal 
Disease states that the “Livestock and Veterinary Management Authority at the central level shall 
establish an appropriate system of surveillance, warning and disease traceability in advance, for 
listed diseases” (Article 8). 
DISCUSSION  
Findings from this analysis demonstrate that countries have policies and governance 
mechanisms to build upon to more effectively address AMR. All countries have already approved 
or drafted a NAP. These NAPs align with key AMR guidance documents, including the GAP, and 
provide an important foundation in creating national interventions to address AMR. NAPs 
provide guidance for establishing awareness initiatives, supporting surveillance and monitoring 
systems, improving infection prevention and control and promoting rational AMU practices. All 
countries reviewed have established, or are in the process of establishing, a multi-sectoral steering 
committee or working group. There are also efforts at the regional level for coordination and 
collaboration on AMR activities. Countries have enacted pharmaceutical and animal husbandry 
laws to regulate antimicrobial use in animals and agriculture. Policies to regulate the use of 
antimicrobials and address responsible marketing, sales, and manufacturing have been enacted. 
Some countries require prescriptions to use antimicrobials in animals, and most encourage 
responsible advertising of antibiotics. Several countries prohibit counterfeit drugs and overselling 
of antimicrobials.  
  
74 
Many countries are also starting to implement bans of specific antibiotics for use in 
animals and have established policy goals to eliminate or restrict the nontherapeutic use of 
antimicrobials. NAPs promote awareness raising initiatives focusing on different target 
populations and countries are increasing their participation in national and global awareness 
raising events. Policy support for countries to develop surveillance and monitoring systems 
specific to AMR and AMU were identified in each country. Additionally, countries have policy 
support for reporting disease occurrences for specific diseases, while other laws mandate the 
establishment of surveillance systems for specific infectious diseases. NAPs describe infection 
prevention and control efforts to address AMR in animals and agriculture as well as several 
countries have already enacted policy guidelines on infection prevention and control.  
Critical gaps in AMR policy in this region were identified. Legally binding delegation of 
duty and/or authority to act on AMR issues are limited. Specific, detailed regulation of the use of 
antimicrobials is also weak. Countries often lack adequate guidelines for the distribution of 
antimicrobials. For instance, guidance on who and where antimicrobials can be sold, and who 
may legally administer antimicrobials is very limited in most countries. Laws regarding who can 
sell drugs for use in animals and where drugs can be sold are often ambiguous. For example, in 
Viet Nam, minimal requirements for drugs stores for veterinary pharmaceuticals are described in 
policy. Vietnamese law states that the Health Minister will specify geographic areas where drug-
retailing establishments are allowed. However, the law does not mention important details such as 
if sales of veterinary pharmaceuticals have separate requirements from human pharmaceuticals. 
In Cambodia, no specific legal provisions on where antimicrobials can be sold were found. The 
Cambodian Law on Animal Health and Production states that distributors, wholesalers or retailors 
of veterinary medicines must be represented by a veterinarian. This law does not mention whether 
veterinary medicines, including antibiotics, may only be sold in pharmacies or could be sold in 
other shop types.  
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Although some countries have established goals to reduce the nontherapeutic use and use 
of critically important antimicrobials, binding policy is currently minimal and no country has 
established a reduction target for AMU. As surveillance and monitoring activities progress, 
informed reduction targets can be established to better understand the impact of interventions and 
to document national progress.  
Most countries do not have legislation that specifically bans the use of antimicrobials for 
use as growth promoters or for disease prevention. There is also a lack of policies regulating the 
use of antimicrobials in animal feed. Although policies to ensure quality standards for the 
distribution and use of animal feed exist in all countries, these policies are often limited in scope. 
For instance, they do not explicitly mention or describe antimicrobial additives. These limitations 
in policy may influence the overuse and misuse of antimicrobials in animal productions systems. 
Evidence from high-income countries demonstrates that curbing nontherapeutic and therapeutic 
use of antimicrobials can reduce resistance (Agersø et al., 2011; van den Bogaard et al., 2000; 
Agersø et al., 2013).  
Blanket bans or other policy measures to reduce the nontherapeutic use of antimicrobials 
should be complimented with stakeholder engagement, awareness raising activities and 
substantial investment in infection prevention and control initiatives. Additionally, bans should be 
based on scientific recommendations grounded in evidence. When countries are adapting new 
policy, pilot programs should be used to understand the effectiveness of these policies before full 
scale implementation. This is particularly true of changes in regulatory policies such as 
prescription requirements because these are context specific and depend on different factors such 
as the number of veterinarians in a district or province and farmers access animal healthcare. 
Such policy interventions are highly context specific compared to other AMR policies, such as 
surveillance policy that can be a bit more standardized across countries.   
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Very little AMR focused policy considers the environment. As countries further 
strengthen their national strategies to address AMR there needs to be greater consideration for the 
environment. Countries can address environment threats posed by AMR by including 
environmental regulators in the development and implementation of NAPs. National regulations 
should be established that require monitoring and controlling the spread of AMR into the 
environment targeting different exposure pathways. Biosecurity at the farm level can help to 
reduce the amount of residues spread into the environment. Environmental regulators can also 
establish national targets for maximum levels of antimicrobials discharged during manufacturing 
pharmaceutical products. All countries have agencies designated to address environmental issues 
as they relate to public health. The current duty of these agencies does not appear to include 
monitoring AMR-related impacts, or to respond such impacts. There is potential for these 
agencies to oversee the environmental aspects of AMR. For instance, Myanmar has an 
Environmental Conservation Department under the Ministry of Conservation and Forestry that is 
charged with carrying out environmental impact assessments and managing environmental 
pollutants. By delegating a mission or duty this agency could also monitor local environments for 
additions of antimicrobial residues, and related impacts from AMR.  
Regulation for the control of labeling on antimicrobials among the countries reviewed is 
minimal. Labeling has an important role to play in communicating to the animal producer the 
what is included in the product particularly animal feed, describing the scarcity of antibiotics and 
ensuring product registration compliance. Some countries lack policy that explicitly prohibit fake 
or counterfeit veterinary pharmaceuticals. Updating policy language to prohibit fake or 
counterfeit products is important for reducing the manufacturing, use and distribution of these 
products.  
An important influencer of AMU policy are standards set by exporting countries. For 
instance, the EU, Australia and the US have put pressure on seafood exporters to reduce the 
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excessive use of antibiotics used in fish (FAO, 2017). Antibiotic residues accounted for 28% of 
EU rejections and 20% of US rejections of aquaculture imports (FAO, 2017). Viet Nam, China, 
Thailand, Bangladesh, and Indonesia have the most frequently rejected aquaculture products 
(FAO, 2017).  In 2012, Australia blocked shipments of fish from Viet Nam after enrofloxacin, an 
antibiotic banned in Australia was detected (Phys.org, 2012). Recently, both Japan and the EU 
have imposed temporary bans on Vietnamese fish and seafood due to illegal drug residues. Some 
foreign animal manufacturers are changing their antibiotic use in fish as a result of these bans 
however information on specific regulation changes were not identified (Tuoitre News, 2016). In 
April 2017 the US Food and Drug Administration (FDA) issued an import alert that its district 
offices could detain and test all imports of shrimp and prawns from Malaysia (Bloomberg, 2016). 
Fish products from different Southeast Asian countries are often exported through Malaysia 
(FAO, 2017). Malaysia’s Ministry of Health responded by announcing that it would tighten 
controls at processing plants and assume the authority to issue certificates of origin from 
chambers of commerce (Bloomberg, 2016).  
Policies to address infection prevention and control are varied. Increased support to 
improve animal health should be considered by all countries with a focus on herd health and herd 
immunization programs, promoting and enforcing agricultural best management practices, and 
enforcing biosecurity standards. These policies will in turn reduce the need for antimicrobial use 
in animals and agriculture. Guidelines for infection prevention and control should be adapted for 
each country context and consider local farming systems. Additionally, a focus should be given to 
animal health workers and farmers for infection prevention and control training. The Dutch 
government has made substantial investments in infection prevention and control efforts at the 
farm level. One measure created for improving infection prevention and control is the Farm 
Health Plan (FHP) established by the Dutch Taskforce Antibiotic Resistance in Animal 
Husbandry. The FHP requires farms to work with their veterinarian to develop a plan that 
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identifies farm-specific risk factors for infectious diseases and designs specific management 
measures to control and prevent these diseases. This measure along with other regulatory and 
policy actions have been credited with contributing to a 56% nationwide reduction in 
antimicrobial use in farm animals from 2007 – 2012 (Speksnijder et al., 2014).  
Finally, no AMR or AMU surveillance or monitoring systems exist in any of the 
countries included in this review. Efforts are currently underway in countries to assess current 
laboratory capacity for AMR surveillance and plans for developing these systems are included in 
NAPs. Surveillance systems are critical for building the evidence base and informing AMR 
programs and interventions. Surveillance is also paramount in detecting and responding to disease 
outbreaks. Most high-income countries have developed surveillance systems on AMR and for 
some countries, such as Japan, this information is used to inform risk management practices for 
antimicrobial use in animals. Japan uses information gathered from the Japanese Veterinary 
Antimicrobial Resistance Monitoring System (JVARM) to regulate what antimicrobials can be 
added to animal feed. Japan relies on the following risk management measures, informed by 
international standards, to control what substances are added to animal feed: (1) substances which 
pose risk to human health are not designated as antibiotic feed additives; (2) specifying applicable 
animal species, breeding stages (products for lactation period, for fattening period, etc.); and (3) 
standard amounts to be added in feed. In addition, Japan conducts an annual national survey 
under the framework of JVARM, to identify trends in AMR and to evaluate the effectiveness of 
each risk management measure (Japan Ministry of Forestry and Fisheries, 2017).  
Common gaps in AMR education and awareness policy include limited coordination 
between sectors. Coordination between ministries of agriculture and education could improve 
AMR education in undergraduate and graduate curricula, and could also improve continuing 
education programs focused on veterinary, livestock, and agricultural professionals. Further, 
NAPs typically have limited or no specific details about AMR awareness raising activities or 
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training programs. Most activities on awareness described in NAPs focus on annual campaigns 
and do not typically describe ongoing efforts. Awareness raising campaigns have received 
widespread support; however, there is limited evidence to support their effectiveness to raise 
awareness or impact antimicrobial use (Huttner et al., 2010). Awareness campaigns in Europe 
implemented between 1997 and 2007 have been associated with a 6.5–28.3% drop in the mean 
level of antibiotic use in humans (Huttner et al., 2010; Filippini et al., 2013). However, this 
finding should be interpreted with caution as many other policy initiatives and regulatory 
activities were implemented during this time period.  
Although research documenting the implementation of policies in the countries reviewed 
is limited, and beyond the scope of this review, there is some evidence to demonstrate that there 
is a significant gap in the implementation and enforcement of existing policy. For countries that 
have already banned certain antibiotics for use in animals and agriculture the extent to which 
these policies have been implemented is questionable. For instance, in Viet Nam, a 2013 study 
found that at least 45 antibiotics some of which have been banned (e.g. chloramphenicol) were 
commonly used by farmers and veterinarians for nontherapeutic purposes (Kim et al., 2013). 
Additionally, a 2016 study in Viet Nam found that 58 out of 1,893 animal feed production plants 
inspected, were found to be using banned substances with banned substances identified in 17 out 
of 1,239 animal feed samples and 257 out of 3,972 pigs (AsiaNews, 2016). Research on illegal 
distribution of antimicrobials in animals is limited however we can borrow from examples on 
human use. In some countries that require prescriptions for antibiotic drugs these drugs can still 
be easily purchased over the counter. In Viet Nam for instance, a 2010 study determined that 88% 
of antibiotics were sold without a prescription in urban pharmacies and 91% in rural pharmacies 
(Thuy Nga et al., 2014). A 2016 survey conducted in Indonesia found that 85% of pharmacies in 
Jakarta sell drugs without prescription (Asia News, 2016).  All countries reviewed require that 
drugs be registered with the designated authority before use in animals and humans. However, 
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estimates suggest that Laos has about 2,100 illegal drug retailors and Cambodia has roughly 2800 
illegal medicine sellers and 1000 unregistered medicines on the market (Pincock, 2003).  
Existing policies can be improved to more effectively prevent or reduce the impacts 
AMR. One way to improve existing policies is to interpret and/or enforce polices in ways that 
target the systems and actors that contribute the most to AMR. For example, awareness raising on 
existing policies can target specific groups such as drug retailors, prescribers and animal 
producers. Second, existing policies can be improved by enacting amendments that modify 
language or add enforcement tools that fit the local capacity. Governments can enhance the 
quality of their policy frameworks by ensuring that language used to describe policy is simple, 
clear and understandable with definitions included for key terms such as ‘misuse’, ‘harm’ or 
‘overselling’. Further, governments should identify gaps in enforcement practices, develop 
capacity to fully implement existing and future policy, and undertake awareness raising 
campaigns on existing policies. In addition to clarifying and strengthening AMU guidelines, 
measures to make veterinarians accountable for prescribing practices should be considered to 
promote rational use of antimicrobials. Governments should consider adapting policy that 
prevents pharmaceutical companies from providing financial incentives to veterinarians for 
prescribing antibiotics.  
CONCLUSION 
This analysis demonstrates that countries have policies that can be used and built upon to 
more effectively address AMR at the national level. Most countries have enacted pharmaceutical 
and animal husbandry laws to regulate the use of antimicrobials in animals and agriculture. Many 
countries require prescriptions for use of antimicrobials in animals, and most encourage 
responsible distribution of antimicrobials through advertising and labeling standards. Several 
countries prohibit counterfeit drugs and overselling antimicrobials. Many countries are also 
starting to implement bans of specific antibiotics for use in animals and have established policy 
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goals to eliminate or restrict the nontherapeutic use of antimicrobials. With the development of 
NAPs to address AMR, countries have the foundation to develop AMR/AMU awareness 
initiatives, to provide support for surveillance and monitoring systems, and improve infection 
prevention and control systems.  
Common gaps in existing policy across countries included unclear descriptions of the 
legal use of antimicrobials in animals including weak or nonexistent standards for limiting or 
reducing the use of critically important and nontherapeutic use of antimicrobials; limited policy 
support for awareness raising and surveillance activities; and limited formal coordination 
mechanisms for inter-sectoral coordination between sectors. Most ministries do not have formal 
AMR coordination mechanisms such as inter-ministerial declarations or memorandums of 
understanding between sectors or ministries. Establishing formal mechanisms for coordination 
between sectors to help improve communication and collaboration for multi-sectoral efforts is 
important. Legislation that specifically bans the use of antimicrobials for use as growth promoters 
or disease prevention has not been enacted for most countries. It is critical that antimicrobial use 
for growth promotion or prophylaxis in animals should be reduced or eliminated however these 
policies should be coupled with adequate investment in improved infection prevention and 
control in livestock. Additionally, many countries lack an explicit description or mandate to 
promote the rational use of antimicrobials in animals.  
Further research into specific use and distribution of antimicrobials is needed and policy 
can support and guide these actions by designating authority or mission to departments and 
setting and prioritizing research agendas. Greater analysis is needed to understand how policies 
are enforced and the political and economic context of national policy frameworks and to identify 
gaps in enforcement. As countries adapt their policies and implement NAPs, the local context and 
capacities must be considered. Countries should strive to use evidence-based solutions; ideally 
evidence gathered in their own country. To make sure that AMR is a priority, countries need to 
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cultivate political commitment to this issue at the national level. As WHO, FAO and other 
international organizations call for further national action on AMR, policy-makers may feel 
pressure to make swift policy decisions to meet international expectations. However, countries 
should be mindful of their approach when adopting new policies, even when policies have been 
effective in other settings.  
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Chapter 5  
 
Antimicrobial Resistance Policy in Asia and the Pacific: Findings from 
an Exploratory Study 
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SUMMARY 
The objective of this analysis is to better understand national regulatory frameworks 
designed to address antimicrobial resistance (AMR) and antimicrobial use (AMU) in the food and 
agriculture sector. Information was obtained during focus group discussions at the 2016 Regional 
Workshop on AMR in Asia and the Pacific, hosted by the Food and Agriculture Organization 
(FAO) Animal Production and Health Commission for Asia and the Pacific (APHCA) and the 
World Organisation for Animal Health (OIE). Twelve countries from South Asia, the Pacific and 
Southeast Asia contributed: Afghanistan, Bangladesh, Bhutan, Cambodia, India, Indonesia, 
Myanmar, Nepal, Philippines, Samoa, Sri Lank and Viet Nam. Focus group discussions focused 
on national policies, including background information about national strategies, local constraints 
and challenges, and proposed AMR policy.  
This study revealed several key findings. Most countries reported existing animal 
husbandry and veterinary pharmaceutical policy that can be used to address AMR. Respondents 
described plans for enacting new policies, many of which focus on developing and implementing 
national action plans. Proposed policies address objectives described in the World Health 
Organization (WHO) Global Action Plan (GAP) to address AMR, particularly awareness raising 
activities, and building surveillance and monitoring capacity. Respondents identified several 
stakeholders that are critical to shaping AMR and AMU policies including veterinary 
pharmaceutical associations, farmers’ associations, and ministries of agriculture. Common gaps 
and constraints in addressing AMR described by respondents include limitations in infrastructure, 
and a lack of financial and human resources. This study can be used to shape recommendations 
for AMR and AMU policy interventions and inform existing and future policy. Findings from this 
analysis can support countries in allocating finite resources to create a more effective enabling 
environment to respond to AMR.  
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INTRODUCTION 
Antimicrobial resistance (AMR) poses a significant risk to animal and human public 
health around the world (WHO, 2016; FAO, 2016). With the growth of global trade and travel, 
resistant microorganisms can spread very quickly throughout the world leaving no country 
invulnerable (OECD, 2016). Drug-resistant bacteria are responsible for 25,000 deaths in Europe 
annually and with resistance levels rising many infectious diseases may one day become 
untreatable (ECDC, 2009). AMR affects high- and low-income countries alike, however, 
estimates indicate that AMR will have an “increase in extreme poverty” and will have a 
disproportionate impact on the economics of low-income countries (World Bank, 2016). 
Immediate concerns for AMR are similar across low- and middle-income countries. Many of 
these countries are experiencing increasing rates of drug-resistant tuberculosis (TB), malaria, and 
HIV/AIDS and threats to livestock and food security (WHO, 2014; Gelband et al., 2014; 
Archawakulathep et al., 2014). Without effective and timely interventions, AMR associated 
human mortality is expected to increase from 700,000 global deaths in 2014 to over 10 million by 
the year 2050 (O’Neill, 2016). In addition to the impact on morbidity and mortality, AMR also 
causes a substantial economic burden. The U.S. Centers for Disease Control and Prevention 
(CDC) estimates that in the U.S. alone, the annual impact of antibiotic resistant infections on the 
economy is $20‐35 billion in excess health care costs (CDC, 2013). Economic losses linked to 
AMR are anticipated to exceed $100 trillion annually by 2050 (World Bank, 2016).  
The emergence and spread of AMR is influenced by antimicrobial use in humans and 
animals including the misuse and overuse of antimicrobials (Hershberger et al., 2004; Speksnijder 
et al., 2014). Low- and middle-income countries often have limited regulation on antimicrobials 
including weak drug quality assurance systems creating conditions for the misuse of 
antimicrobials (Gelband & Delahoy, 2014). In some countries, antibiotics are widely used in 
healthy food-producing animals for non-therapeutic purposes including promoting growth and 
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preventing disease (Landers et al., 2012). Research suggests that antimicrobial resistant microbes 
carried by infected animals can transfer to humans and cause disease. Resistant microorganisms 
carried by food-producing animals can spread to humans through consumption of contaminated 
food, direct contact with animals, or through environmental vectors like contaminated water 
(Marshall et al., 2011). In South Africa, Salmonella enterica, Escherichia coli (E. coli), and 
Enterococcus spp. have been found resistant to sulfonamides and tetracycline in food animals and 
domestic pets (Mendelson and Matsoso, 2015). The 2016 O’Neill Review on AMR, suggests 
there is a growing consensus that unnecessary use of antibiotics in animals and agriculture is a 
significant concern for human health. (O’Neill, 2016). 
METHODS 
To better understand the policy environment to address AMR and AMU, representatives 
from twelve countries were asked during focus group discussions to describe their current policy 
to address AMR and AMU in animals and agriculture. Respondents included representations 
from ministries of agriculture working on AMR in different capacities. Countries were asked to 
provide information on the following questions as they relate to AMR and AMU: (1) identify 
current policy to address AMR and AMU; (2) describe planned policy; (3) identify key 
institutions for implementing policies; (4) identify key stakeholders in shaping AMR and AMU 
policy; (5) describe steps to ensure policy compliance; (6) identify determinants of AMR and 
AMU policy; and (7) describe constraints and challenges to policy compliance. The focus was on 
AMR and AMU in animals and agriculture however human health policy was also discussed 
where applicable, including pharmaceutical laws that encompass both animal and human 
antimicrobial use. Participating countries included Afghanistan, Bangladesh, Bhutan, Cambodia, 
India, Indonesia, Myanmar, Nepal, Philippines, Samoa, Sri Lank and Viet Nam. This policy 
information was gathered during the 2016 FAO Animal Production and Health Commission for 
Asia and the Pacific (APHCA) and OIE Regional Workshop on AMR in Asia and the Pacific 
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funded by the United States Agency for International Development (USAID).  By examining 
country’s current and planned policies to address AMR, this analysis contributes to a more 
comprehensive understanding of countries regulatory frameworks to protect public and animal 
health from AMR and identifies where gaps still exist.  
RESULTS 
Current policies 
Eleven of the twelve participating countries identified at least one current national policy 
used to address AMR and AMU. Common components of these policies reported included 
regulations to limit access to antibiotics including feed supplement acts, drug manufacturing 
regulation and control, food safety acts, and animal disease acts. Respondents frequently reported 
that AMR and AMU policies focused on animals and agriculture were limited. Drug and food 
laws related to human health were frequently reported. For example, Bhutan described seven 
laws, five of which focused on AMR and AMU in humans. The majority of the policies were 
enacted within the last ten years. A few are older food and drug regulations enacted in the 1940s.  
 
Planned Policies  
Every country reported policy that will be enacted, or areas for which policy will likely 
be developed. For specific details about each country, see Table 5-1. The majority of countries (8 
of 12) reported plans for strengthening regulations to ensure rational use of antimicrobials. 
Common policy goals included development and implementation of manuals and national 
guidance documents for AMU. More than half of the countries (7 of 12) identified plans for 
improving AMR and AMU surveillance and monitoring. Some countries described activities to 
strengthen or establish policy or tools to address AMR. One country described plans to strengthen 
existing legislation. Another common theme of planned policy included efforts to improve multi-
sectoral coordination. Five countries mentioned establishing or strengthening multi-sectoral 
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collaboration to address AMR particularly for finalizing NAPs. Afghanistan reported drafting a 
NAP on AMR through multi-sectoral collaboration:  
“The Ministry of Public Health and the Ministry of Agriculture (AMR) focal 
points are working to draft the AMR national action plan (NAP). The NAP will 
determine the national strategy for addressing AMR until 2020. AMR focal points 
participated in an AMR workshop in Morocco in March 2016. The NAP should 
be finalized by 2017 for implementation.” – Afghanistan 
 
Myanmar reported similar plans: 
 
“Planned AMR/AMU policies include monitoring and control of AMR/AMU 
strategy, Action Plan of National Veterinary drugs residues control program and 
chemicals in animal production based from the strategy needs to be developed 
(registration is in place but authorization, usage, prescription, labeling 
requirement and pre and post market surveillance need to be enforced), A 
manual of procedures needs to be developed.” – Myanmar  
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Determinants of AMR and AMU Policy 
Table 5-1. Countries response to the question “what are planned national policies to 
address AMR and AMU in food and agriculture?” 
Country Planned policy 
Afghanistan 
• Veterinary drug importation and regulation 
• Focal points from the Ministries of Public Health and Agriculture are drafting an AMR 
National Action Plan 
Bangladesh 
• Strategy on AMR Prevention 
• Establish a multi-sectoral approach for planning and coordination of activities related to 
AMR. 
• Promote and ensure rational use of antimicrobials 
• Promote and strengthen infection prevention and control measures 
• Review, update, and strengthen regulatory provisions 
• Institutionalize a surveillance system for AMR containment   
Bhutan 
• Draft NAP 
• Establish a governance structure to spearhead activities on AMR 
• Promote rational use of AMs at all levels of human and veterinary healthcare. 
• Institute surveillance and monitoring system of AMR & antimicrobial use. 
Cambodia 
• Reduce antimicrobial use in food-producing animals. 
• Inter-sectoral collaboration. 
• Create an enabling regulatory framework. 
• Establish surveillance and monitoring system. 
• Ensure prudent use of antimicrobials. 
• Inspect farms, slaughterhouses, processing facilities, laboratories, private research and 
academic institutions, veterinary drugs and vaccines, veterinary services, and feed product 
outlets. 
• Meat quality control including testing of drug residues and microbial contamination. 
• Encourage local production of veterinary medicines and vaccines. 
• Establish strong collaboration between MoH and MAFF. 
• Establish a strong regulatory framework for authorization and control of the quality of 
veterinary medicines. 
• Develop Essential Medicines List for the animal sector. 
• Conduct pre-licensing safety evaluation of antimicrobials for veterinary use; consider the 
potential for resistance to drugs used in human medicine. 
• Ban non-therapeutic use of antimicrobials (e.g. growth promoters). 
• Restrict the use of antimicrobials identified as critically important in human medicine in 
food-producing animals. 
• Require prescriptions for all antimicrobials used for disease control in food-producing 
animals. 
• Measure and monitor antibiotic residue in food products from animal sources. 
• Establish monitoring system for AMR in food-producing animals. 
• Implement the Codex Alimentarius and OIE guidelines related to antimicrobial resistance 
• Promote better animal husbandry and good farming practices 
India 
• Inter-Sectoral Coordination Committee on Antimicrobial Resistance 
• Technical Advisory Group on Antimicrobial Resistance 
• Core Working Group on Antimicrobial Resistance 
Indonesia 
• Develop national-level AMR-AMU Strategy 
• Implement integrated surveillance 
• Develop manual on the prudent use of antimicrobials 
• Define central and local government’s responsibility in supervising production, supply, and 
distribution of veterinary drugs. 
• Limit access to antimicrobials 
• Veterinary drug restriction and certification 
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Respondents were asked to identify the main determinants of AMR and AMU policies in 
their respective countries. The most common response was the increasing concern for human 
health with nine out of twelve countries reporting this as the key determinant of AMR and AMU 
policy. More than one third of countries (4 out of 12) reported increasing international concern of 
AMR as another important driver of policy. Other responses included inter-sectoral collaboration 
and the socio-economic consequences of adverse trade outcomes as influencing AMR policy. The 
intensification and changing livestock production systems were mentioned by a few countries. 
Respondents also commonly discussed concern regarding the transfer of antibiotic residues and 
resistant bacteria from agriculture to the environment. Two countries mentioned concern for 
animal health as a key driver of AMR policy. Three countries described research or surveillance 
as determinants of AMR and AMU policy. For instance, a respondent from Indonesia described 
findings from monitoring activities of AMR in animal products that revealed a rising prevalence 
of AMR, particularly in poultry products, as a driver of AMR policy. A respondent from Samoa 
stated that the results of a 2016 country situational analysis on AMR was a key driver of AMR 
policy. The following two quotes demonstrate national determinants of AMR and AMU policy.  
“Antimicrobials are critical in the management and treatment of infectious 
diseases… AMR has serious socioeconomic implications and is of global 
concern. There is a global drive toward combating AMR and Bhutan supports 
the international community” – Bhutan  
 
“Overuse and misuse of antimicrobials is acknowledged. (Drivers of AMR and 
AMU policy include) Increased multi-resistant organisms for commonly used 
antimicrobials; high treatment costs; low quality and inefficient drugs are 
prevalent in the local market; and need for available information on evidence-
based risk due to AMR/AMU” – Sri Lanka 
 
Institutions for implementing policies and legislation  
Government level entities were the most commonly identified institution primarily 
responsible for implementing AMR/AMU policy. Ministries of health, agriculture, or the 
economic sector were typically mentioned. Private entities were also frequently identified, 
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primarily pharmaceutical companies, health care facilities, medical and veterinary practitioners, 
and farmers and livestock companies. Community and civil sector actors were also identified as 
crucial for implementing AMR and AMU policy in the food and agriculture sector. These include 
medical and veterinary associations, research institutions, and consumers.  
Stakeholders  
Respondents identified a range of key stakeholders critical in shaping AMR and AMU 
policies. The most commonly identified stakeholders included veterinary pharmaceutical 
associations, farmers’ associations, animal processing plants, veterinary medical associations, 
economic and trade sectors and researchers and academics. Ministries of animal, agriculture, and 
human health ministries were picked by every respondent as important stakeholders. International 
organizations including FAO, the WHO and OIE were also identified. Representative from six 
counties reported livestock producers or farmers as stakeholders in shaping AMR and AMU 
policies. For more details, see Table 5-2. Respondents from Philippines describe key stakeholders 
as the following:  
“Government Regulators including the Dept. of Health, Dept. of Agriculture, and 
Dept. of Interior and Local Government; law makers and budget allocators; 
manufacturers, distributers, importers, retailers (drug stores); animal producers; 
medical and veterinary practitioners; and international organizations” – 
Philippines 
 
Enforcement 
Participants were asked to identify efforts to ensure compliance of AMR and AMU 
policy. The most common responses focused on monitoring and surveillance of AMR and AMU. 
Other common responses included inspection and regulation of antimicrobial agents, and 
ensuring registration of antimicrobials. Plans for ongoing efforts included implementing good 
veterinary and agricultural practices, awareness raising campaigns, capacity building and support 
from regulatory authorities. Viet Nam, India, and Indonesia described plans for strengthening 
enforcement of existing policies through enhancing law enforcement, and strict compliance with 
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regulatory authorities on AMR and AMU policy See Table 5-2. for specific country responses. 
Viet Nam describes processes for improving policy enforcement:  
“(To ensure policy compliance) develop AMR awareness raising material, 
enhance AMR awareness for key stakeholders, strengthen inspection and 
monitoring of the production, trading and use of antibiotics and strict 
sanctioning for violations.” – Viet Nam  
 
 
Table 5-2. Responses to the question “how will you ensure or improve compliance to 
AMR and AMU policy?”  
Country Efforts to improve enforcement and compliance 
Bhutan  
• Monitoring report of Drug Regulatory Authority Pharmaco-vigilance system on 
antibiotics 
• Bhutan Agriculture and Food Regulatory Authority reports on food monitoring 
Cambodia  
• Veterinary drugs shall be registered for specific uses, in accordance with their 
risks on human and animal health. 
• No person or legal entity will be allowed to trade veterinary drugs unless they 
have a license from the Department of Agriculture, to import, export, package, 
repackage, inventory, distribute and wholesale in the Kingdom of Cambodia. 
• Procedure and standard for registration had been defined by the proclamation of 
MAFF that regulate the purchase, prescription, and use of [hazardous] veterinary 
drugs in accordance with their risk. 
India   
• Regular data collection and information 
• Strengthen surveillance system for AMR 
• Massive awareness among stakeholders 
• Requisite capacity building 
• Strict compliance by regulatory authorities 
Nepal   
• Implementation of OIE PVS Gap Analysis and Recommendations 
• Approval of veterinary drug act and implementation 
• Good veterinary practices 
• Code of conduct for veterinarians and veterinary para-professionals on proper 
use of antibiotics 
Philippines   
• Monitoring and surveillance of AMR/AMU 
• Registration of antimicrobial agents 
• Inspection and licensing of establishments engaged in the production, 
importation, distribution, and sale of antimicrobial agents 
Samoa  
• The Ministry of Health, in collaboration with other government ministries, 
should raise awareness, and conduct programs and workshops. 
• The lack of funding to conduct further testing of meat and fish products. 
• People smuggling drugs across the border 
Viet Nam  • Develop AMR awareness raising material 
• Enhance AMR awareness for key stakeholders 
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• Strengthen inspection and monitoring of the production, trade, and use of 
antibiotics 
• Strict sanctions for violations 
 
Constraints and Challenges for Policy Compliance 
Seven of the twelve countries identified constraints to AMR policy compliance. The most 
important constraints, according to the respondents, was capacity: the lack of infrastructure, 
limited financial resources, insufficient laboratory capacity, and the lack of human resources 
including technical support and expertise. Low awareness of AMR among the general population, 
as well as key populations including veterinarians, was mentioned as an important constraint. A 
few countries mentioned inter-sectoral coordination and gaps in legal and regulatory controls as 
constraints or barriers to compliance of AMR policy. See Table 5-3. for more details. 
Table 5-3. Constraints to AMR and AMU policy compliance 
Country Constraints to compliance 
Bangladesh  
• Lack of adequate manpower, lack of skills, lack of necessary logistics, financial 
constraints. 
Bhutan  
• Manpower shortage, skills and capacity, laboratory facilities, research capacity, limited 
awareness and knowledge of AMR 
Cambodia  
• Shortage of laboratories 
• Variation in methods (laboratory testing) 
• Lack of information: limited data in AMU and AMR in food producing animals 
• Limited inter-sectoral collaboration 
• Insufficient knowledge and training: lack of training on appropriate use of 
antimicrobials in food producing animals and insufficient understanding of their 
potential contributions to AMR in humans. 
• Perverse incentives: increasing sales profits by veterinarians and farms influence the 
inappropriate use of AMs 
• Gaps in legal and regulatory controls: insufficient legislation and regulations to restrict 
the availability and use of AMs in food-producing animals 
Myanmar  
• Infrastructure, human resources, laboratory capacity upgrading and testing 
• Low awareness 
• Need for contributions from citizens, ethicists, policy makers, practitioners and industry 
• Policy, advocacy, innovation and research, surveillance and funding, Post marketing of 
veterinary drugs 
Samoa  
• The lack of fund to conduct a further testing of meat and fish product 
• People smuggling drugs across the border 
Sri Lanka  • Regular monitoring, targeted surveillance, failure to record treatment 
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Viet Nam 
• Lack of awareness of AMR and AMU of farmers and consumer 
• Lack of financial resources 
 
DISCUSSION 
Recently, a range of policy recommendations have been proposed to combat AMR in 
humans and animals (WHO, 2015; Dar et al., 2016; Landers et al., 2012; FAO, 2016).  In 2011, 
WHO’s World Health Day was dedicated to AMR with the release of a policy package (WHO, 
2011). This policy package outlines six priority areas where action is needed for countries to 
adequately address AMR. In 2015, the World Health Assembly, in coordination with the World 
Organization for Animal Health (OIE), and the Food and Agriculture Organization (FAO), 
adopted a Global Action Plan (GAP) on AMR. The GAP outlines specific recommendations for 
countries to prevent and decrease the spread of AMR. A key recommendation of the GAP is the 
development of country specific National Action Plans (NAPs). The GAP expects that all WHO 
Member States will develop their own NAPs in line with the global plan by May 2017 (GAP, 
2015). To effectively strengthen national policy among countries in Asia, understanding 
regulatory activities and planned policy is essential.  
This analysis demonstrates that across the twelve countries there are ongoing efforts to 
strengthen and adapt policy to address AMR and AMU. All respondents reported at least one 
national policy currently enacted or drafted to address AMR and AMU. Most national policy 
either directly or indirectly addressing AMR and AMU, has been enacted or updated in the last 
ten years. Countries report plans for developing new policy or strengthening existing policies. 
Most planned updates focus on addressing objectives outlined by the GAP. Plans to update policy 
frequently concentrate on rational use policies aimed at optimizing and promoting responsible 
antimicrobial use. Efforts to draft and implement NAPs were frequently described as planned 
policy actions.  
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Respondents described plans for improving multi-sectoral coordination. Most strategies 
include increasing coordination and establishing mechanisms to foster collaboration between 
human health and animal and agriculture sectors. Coordination between animal and agriculture 
ministries and ministries or departments related to the environment, trade or education, were not 
described. This is a critical gap as multi-sectoral coordination helps countries increase 
commitment, awareness and action from different sectors to ensure appropriate and effective 
AMR response (GAP, 2015; Nweneka et al., 2009). Improving infection prevention and control 
(IPC) efforts in animals and agriculture was not commonly identified as a policy priority by the 
responding countries. This is an important policy area to support, as IPC efforts in low and 
middle income countries are chronically underprioritized and underfunded (Dar et al., 2016). 
Building political consensuses and support for these initiatives is necessary to increase IPC 
capacity in the region and decrease the need for antimicrobials. Another key area that was not 
described is the need to increase regulation on sales and distribution of antimicrobials particularly 
veterinarians right to prescribe and sell antibiotics. As countries continue to strengthen policy 
economic incentives should be eliminated by decoupling veterinarians’ right to both prescribe and 
sell antibiotics.  
There is consensus among countries regarding the institutions key to implementing AMR 
and AMU policy with a focus on ministries of health and agriculture. Specific regulatory 
authorities within ministries were infrequently described as agencies critical to implementing 
AMR and AMU policy. Plans for improving compliance with AMR and AMU policy were 
highlighted by many respondents. Common responses included strategies for capacity building 
and strengthening implementation of existing policies. To more effectively address gaps in policy 
compliance, countries should conduct comprehensive assessments and compare implementation 
best practices with existing policy (Dar et al., 2016).  
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Consideration of stakeholder engagement in policy implementation is an important step 
countries should take to reduce AMR (Archawakulathep et al., 2014). Several respondents 
identified low awareness among stakeholders on AMR as a major constraint to AMR/AMU 
policy compliance. Stakeholder awareness raising was commonly identified as planned policy. 
Countries identified a variety of stakeholders important in shaping AMR and AMU policies. 
Mostly respondents focused on ministries of animal and human health and departments within 
these ministries. Engaging additional stakeholders would be beneficial, particularly stakeholders 
involved in implementing AMR and AMU policies.  
Concern for human health was the main determinant for improving national AMR policy 
response identified by respondents. Only two countries mentioned concern for animal health as a 
driver of AMR policy. This likely reflects the economic concern of AMR on animal health (FAO, 
2005). Few countries described surveillance, monitoring, or research as determinants or 
influencers of AMR or AMU national policies. This suggests that there is a need to increase 
surveillance and monitoring initiatives and support building laboratory and research capacity for 
AMR. Building this capacity is particularly important for establishing evidence-based policies. 
Currently there is a significant variation in the amount, and type of research on AMR and AMU 
from the countries included in this review (Archawakulathep et al., 2014). Respondents described 
planned activities to build the evidence base on AMR and AMU. However, research outside of 
surveillance and monitoring activities was not explicitly mentioned. WHO and FAO have 
described research priority areas for countries to build their evidence base with a priority on 
understanding AMU and the economic impact of AMR. Research on AMU is particularly 
important to ensure that policies are based on local context and consider the national drivers of 
antimicrobial use. Additionally, monitoring activities on drug quality will be beneficial for 
countries to adopt to curb the production of counterfeit and substandard antimicrobials.  
CONCLUSION 
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Findings from this analysis can inform policy and future recommendations for AMR and 
AMU interventions. Critical gaps that should be addressed at a policy level include limited 
regulation on the use of antimicrobials in animals particularly nontherapeutic use, enhanced 
coordination between sectors, infection prevention and control efforts, low-awareness among key 
stakeholder groups and lack of evidence on AMR and AMU. To address the evidence gap, policy 
should support activities beyond surveillance and monitoring including research to better 
understand AMU and AMR in the national context. Policy-makers should consider infection 
prevention and control initiatives when adapting AMR policy and their great potential for 
reducing the need for antimicrobials. National investments in improved animal husbandry 
practices and disease prevention measures have demonstrated effective at reducing AMU in 
various settings (Dar et al., 2016). Although data regarding the enforcement is sparse, the 
effectiveness of existing policy is likely weakened as a result of insufficient enforcement 
capacity, infrastructure, and funding. Building this capacity is needed to address key constraints 
and challenges including lack of adequate infrastructure and resources such as technical support 
and expertise.  
As AMR continues to receive increased attention and political commitment, countries 
should ensure that appropriate and context specific policies are implemented. Countries often 
prioritize actions described in the GAP, however policy-makers should consider local context and 
national needs when adapting and prioritizing these recommendations into policy. Before full 
implementation of policy countries should consider piloting new polices on a small-scale to 
ensure that new policies are appropriate and meet the needs of the local context. Integrating 
findings from this analysis to inform recommendations made from international organizations, 
government and non-governmental organizations will produce more effective AMR policy 
responses to protect public health from this growing threat. Findings from this analysis can also 
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support the resources allocation process and ensure sufficient funds and resources are 
appropriated to create a more enabling policy environment for AMR response. 
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Chapter 6: 
Conclusions  
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OVERALL CONCLUSIONS  
The intensification of animal production and changes in agricultural practices present 
favorable conditions for the emergence and spread of old and new diseases. Policies to promote 
national animal production should consider potential unintentional disease outcomes such as 
AMR and brucellosis. Consideration of disease prevention and control in developing policies to 
promote animal production is crucial for safeguarding public health. Overall the purpose of this 
research was to characterize and describe national policies to promote animal production and the 
impact and potential consequences of these national policies. Studies in this dissertation provide 
information on the re-emergence of a zoonotic disease and countries current and proposed policy 
framework to manage and protect public health from AMR.  
The first and second analysis in this dissertation focused on understanding the impact of 
national policy decisions and a disease re-emergence event in Thailand. This was considered 
through a cross-sectional study in Thailand examining small-scale goat farmers’ knowledge, 
attitudes and practices associated with brucellosis and through estimating seroprevalence using 
national brucellosis surveillance data. The first analysis supported previous findings that 
brucellosis poses an occupational risk as farmers engaged in high risk behaviors including 
minimal use of personal protective equipment and limited actions when purchasing a new animal. 
This study determined that farmers have knowledge of brucellosis in goats; however, 
understanding of the disease in humans and other animals is limited. Additional important 
findings include that participants perceived that their risk of infection was low with the majority 
reporting that they or a member of their household, were not at risk for brucellosis.  
This analysis helps to identify specific human risk exposure to the disease through animal 
husbandry practices and further highlights the occupational risk of goat farming. Additionally, 
this study identifies areas where knowledge of brucellosis could be strengthened through farmer 
education and training. Future research should consider examining human seroprevalence of 
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brucellosis among farmers to understand how animal husbandry factors influence seroprevalence 
in humans. Additional focus should be on areas where little or no research has been conducted 
such as the eastern region of Thailand.  This research can be used to inform national policy and 
consideration of increased farmer training and education on disease prevention and transmission 
specific to brucellosis and other diseases of concern.  
Results from the second analysis estimating brucellosis seroprevalence using the national 
brucellosis surveillance system data indicate that certain regions of Thailand have higher 
seroprevalence of brucellosis at both the animal and herd level. During the three-year period, 
2013 had the highest proportion of herds that tested positive for brucellosis at 13.80% 
(372/2,695). Provinces in the eastern and western regions of Thailand had the highest proportion 
of animals and herds testing positive during all three years. Contrary to previous research 
indicating the southern provinces as an area of brucellosis concern, this research found the 
southern region to have the lowest herd and animal seroprevalence. Findings from this analysis 
indicate that additional control measures would be beneficial to reduce the prevalence of 
brucellosis in small ruminants in Thailand with efforts concentrated in areas with higher 
prevalence. It is recommended that policy be strengthened to increase DLD testing throughout the 
country to provide a more thorough representation of brucellosis throughout the country. From 
2013 – 2015 27.3% of the total small ruminant population and 7.79% of the total small ruminant 
herd population were tested and included in the national surveillance system. As goat farming 
continues to increase, potential human health consequences should be taken into consideration 
when adapting animal husbandry policy and policies to control brucellosis to ensure appropriate 
initiatives are implemented to control brucellosis. 
Results from analysis of AMR and AMU policy in food and agriculture provides a deeper 
understanding of Southeast Asian countries’ current regulatory framework and capacity to 
respond to AMR. Analysis revealed countries have existing policies that can be used to address 
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AMR at the national level. With the development of NAPs to address AMR, many countries have 
the foundation to develop AMR/AMU awareness initiatives, to provide support for surveillance 
and monitoring systems, and improve infection prevention and control systems. Despite a 
plethora of existing policies, several limitations exist. Policies suffer from weak standards for 
limiting or reducing the use of critically important and nontherapeutic use of antimicrobials. Most 
countries do not have legislation that specifically reduce or restrict the use of antimicrobials for 
use as growth promoters or for disease prevention. Although data regarding the enforcement is 
sparse, the effectiveness of existing policy is likely diluted as a result of insufficient enforcement 
capacity, infrastructure, and funding. Countries in Southeast Asia have established policy to 
address and control the spread of infectious diseases; however, the extent to which these have 
been fully implemented is not yet understood. Future studies on effectiveness of these policies 
would be beneficial.  
The final part of this dissertation was to understand countries awareness of their policy to 
address AMR and AMU, implementation of these policies and national goals for improving AMR 
response. Focus group discussions with key informants on AMR policy provided further insight 
and information on national policies, including background information about national strategies, 
local constraints and challenges, and proposed AMR policy. Results from this analysis suggest 
that some countries have limited awareness of national policies already enacted that directly or 
indirectly address AMR. Countries described plans for enacting new policies with a focus on 
developing and implementing national action plans. Proposed policies address objectives 
described in the World Health Organization Global Action Plan to address AMR particularly 
around awareness raising and building surveillance and monitoring capacity. Overall common 
policy gaps among the countries interviewed included a gap in ongoing efforts to regulate the use 
of antimicrobials, limited coordination between sectors, weak policy support for building 
awareness and limitations in efforts to build the evidence base for AMR and AMU. Additional 
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limitations included limited policy response for improving infection prevention and control 
efforts. Key stakeholders in shaping AMR and AMU policies focused on veterinary 
pharmaceutical associations, farmers’ associations and ministries of agriculture. Common gaps 
and constraints described by countries to address AMR include limitations in infrastructure and 
capacities and lack of financial and human resources. Additionally, low awareness among key 
stakeholder groups and the general population was identified as an important challenge in 
addressing AMR.  
Diseases that are transmissible either directly or indirectly between animals and humans, 
such as AMR and brucellosis, pose significant threats to global animal and human health. This 
research serves as a reminder that food production systems are dynamic and integrated to human 
health. As countries continue to adapt policy to increase food production, consideration of the 
spread and growth of disease need to be considered. Additionally, further work is needed to 
integrate across human and animal sectors.  This was especially evident from the initial 
interviews and review of AMR policies across countries.  Further dialog is needed. Overall, this 
research can be used to inform future evaluation and studies on the impact of agriculture policies 
and infectious diseases in low resource settings, strengthen new policy, inform training and 
education initiatives and provide greater awareness and understanding of factors influencing 
emergence and re-emergence of infectious diseases.  
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APPENDIX 1.  
Table 6.  Key policy documents reviewed addressing antimicrobial resistance and use in animals 
and agriculture  
Country Title and Year  
Cambodia  o Cambodia National Policy to Combat AMR (2014)  
o Law on Animal Health and Production (2016)  
o The law on the amendment of law on management of Pharmaceuticals (1996 updated 2007)  
o National Strategy to Combat Antimicrobial Resistance (2015 – 2017) (2014)  
o National Action Plan to address AMR in agriculture, fisheries, food and livestock (2016 – 2020)  (2016) 
o Prakas No. 225 (MAFF) on technical standards for constructing slaughterhouses  
o Sub-Decree 16 on the Sanitary Inspection of Animal and Animal Products (2003) 
o  Sub-Decree No. 26 ANKr-BK on the Creation and Management of Village Animal Health Agents, (2001) 
o Joint Prakas No. 363 (MAFF MOH) on management of production, import, export and trade of veterinary drugs 
o Sub-Decree No. 14/ANK on the inspection of animal sanitary and animal originated products 
o Prakas on Roles and Responsibilities of Control Agent for Pharmaceutics, Food, Medical equipment, and 
Cosmetics and Private Medical, Paramedical and Medical Aid Services  
o Sub-decree on agricultural standard and materials No. 69 (1998)  
o Sub-Decree No.17 ANKr-BK on the Organization and Functioning of the Ministry of Agriculture, Forestry and 
Fisheries (2000)  
o Sub-decree No.108 on the Management of Slaughterhouse and the Control of Hygiene (2007)  
Indonesia o Law No. 18/2009 on Husbandry and Animal Health. 
o Government Regulations no. 78, 1992 - veterinary drugs control 
o Decree of MoA no. 15, 1994 - veterinary drugs inspector 
o Decree of Moa No. 806, 1994 - the veterinary drugs classification  
o Decree of MoA no. 15, 2008 - monitoring of residue and microbial contamination in animal products 
o Government regulation no. 95, 2012 - the veterinary public health aspects  
o Ordinance no.432 and 435, 1912 
o Government Regulation no. 15, 1977  
o Government Regulation no. 78, 1992 control of veterinary drugs 
o Decree of MoA no. 15, 1994 the veterinary Drugs Inspector 
o National Action Plan on AMR in Indonesia (2017 – 2019)  
o Food and Medicine Supervisory Board (Badan Pengawas Obat dan Makanan) regulation No. HK.00.05.3.02706 
of 2002 on Medicine Promotions  
o Decree of MOH No 189/Menkes/SK/III/2006 on National Medicine Policy  
o Kebijakan Obat Nasional (National Medicine Policy), 2007 Ministry of Health, Jakarta 
o Decree of the Minister of Oceanic and Fisheries no. 26, 2002  
o no. 4158, 2003 the veterinary drugs used in aquaculture. 
o Consumer Protection Law no. 8, 1999, article no.19 responsibilities of the producers to protect consumers from 
deviations of their products 
o Decree of MoA no. 806, 1994 the veterinary drugs classifications 
o Food Law no. 7, 1996, article no.20 and 21 food quality assurance and laboratory testing for food 
o Government regulation no.22, 1983 the Veterinary Public Health aspect 
o Decree of MOA no. 426, 1994 establishment and operations of the Quality Control Laboratory for Livestock 
Products 
Lao PDR o Law on Drugs and Medical Products (2011) 
o Law on Livestock Production and Veterinary Matters (2008) 
o Law on Agriculture (1998) 
o Law on Health Care (2005) 
o Revised National Medicine Policy (2003) 
o National Food Safety Policy (2009) 
o Ministerial Decision on Management Animal Clinics and Veterinary Products Shop  
o Ministerial Decision on the Basic Principle for the Application of Sanitary and Phytosanitary Measures in Plant 
and Animal Product Administration, No. 0039/MAF (2012) 
o Roles, Tasks and Responsibility of the Department of Agriculture and Agriculture Extension (1992) 
o List of Essential Medicines Of Lao, Guidelines On Drugs  
o Decree on the Prevention and Control of Animal Diseases (2012) 
o Technical Norms on Livestock and Livestock Product Management (2000) 
o Ministerial Decision on the Organization and Operation of Sanitary and Phytosanitary Enquiry Point (2011) 
o Regulation on Food Registration (1994) 
o Regulation Governing Drug Registration No. 1441/MOH  
o Prime Minister’s Decree on Livestock Management PM (1993) 
o Regulation on Livestock Management (1997) 
  
114 
Myanmar o Animal Health and Development Law (17/93) 
o Animal Husbandry and Health Law under amendment to better cover veterinary drugs  
o Livestock Development Law (1999) 
o National Food Law (1997) 
o Environmental Protection Law 
o Union of Myanmar National Drug Law (1992) 
Viet Nam o Law on Veterinary Medicine (2015) 
o Law on Food Safety (2010) 
o Circular No. 10/2016/TT-BNNPTNT “Issuing the list of approved and prohibited veterinary drugs” (2016) 
o (Ministry of Health, National Action Plan on Combatting Drug Resistance, (2013-2020) (2013) 
o Drug Law 105/2016/QH13  
o Pharmaceutical Law (2005) 
o Animal Health Law (2015) 
o Circular No. 13/2016 / TT-BNN dated 02/6/2016 Management of Veterinary Drug 
o Veterinary Ordinance 18/2004/PL-UBTVQH11 promulgated on 29 April 2004 by National Assembly of The 
Socialist Republic of Vietnam. 
o Decision No 03  /2009/TT-BNN regulating “Labeling  of Veterinary Products” (2009)  
o Inter-Ministerial Circular No. 16/2013/TTLT-BYT-BNN&PTNT (2013) 
o Circular 39/2013/ TT-BYT Regulations on management of medicines for human use on non-commercial imports 
and exports 
o Government Decree 33/2005/ND-CP dated 15 March 2005 stipulating implementation of a numbers of articles of 
the Veterinary Ordinance 18/2004/PL-UBTVQH11. 
o National Action Plan On Combatting Drug Resistance (2013 – 2020) 
o Viet Nam Integrated One Health Action Strategic Plan for the period (2016-2020) 
o Decision No 51/2009/TT-BNNPTNT “Veterinary Hygiene Conditions for Veterinary Drug Production and 
Trading Enterprises” (2009)  
o Decision No 10/2006/QD-BNN regulating “Procedures for Production, Registration, Import and Circulation of 
Veterinary Drugs, Materials for Veterinary Drug Production, Biological Products (pro-biotics), Micro-organisms 
and Chemicals” (2006)  
 
